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Maine Center for Disease Control and Prevention (Maine CDC) has published an annual report 
on infectious diseases in Maine for the last 20 years. This report is prepared by the Division of 
Infectious Disease and is intended to provide an overview of notifiable infectious diseases of 
public health importance in Maine.   
 
We could not produce this report without the continued support of our healthcare and public 
health partners throughout the state. We greatly appreciate all of the laboratories, healthcare 
providers, childcare centers, school nurses, veterinarians and others who provide disease 
surveillance information. Considerable time is spent assisting Maine CDC with infectious 
disease investigations and disease control measures that affect Maine residents. Public health 
partners’ active and critical role in the infectious disease surveillance cycle informs statewide 
policies and programs that protect our residents from infectious disease through health 
promotion, disease prevention, and early detection, containment, and treatment.   
 
We appreciate and encourage your vigilance in the effort to protect the people of Maine through 
timely, complete, and accurate notifiable infectious disease reporting. It is through these 
collaborative efforts that we are able to respond to emerging infectious disease threats and 
prevent outbreaks.   
 
We hope you find this report useful as we all work to protect and promote the health of Maine’s 
residents. As always, we welcome your feedback on how we can provide more useful disease 
information to you, our partners.  
 
For more information on what, when, and how to report infectious diseases please see 
Appendix H (Notifiable Conditions List) of this report, visit our website at 
www.mainepublichealth.gov, or call 1-800-821-5821.      
  
 
 
 
 
 
Lori Wolanski, MPH 
Director, Division of Infectious Disease 
Maine Center for Disease Control and 
Prevention 
Stephen Sears, MD, MPH 
State Epidemiologist 
Maine Center for Disease Control and 
Prevention 
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2013 Infectious Disease Surveillance Highlights 
 
• Tickborne diseases continued to increase in 2013, with 1,376 cases of Lyme disease 
reported. This highlights the importance of awareness and prevention efforts regarding 
tickborne diseases in Maine. 
o Both babesiosis and anaplasmosis increased in 2013. Babesiosis cases tripled 
and anaplasmosis cases almost doubled. The largest increases were seen in the 
Southern and Midcoast areas of the state. 
o In 2013, the first case of Powassan since 2004 was reported in a female in the 
Midcoast district. 
• Reports of giardiasis increased in 2013. The rate of giardiasis in Maine (16.4 per 
100,000 persons) is now three times the national rate (4.8 per 100,000 persons). 
• Active tuberculosis cases in Maine residents continued to be reported at higher numbers 
than previous years. In 2013, an outbreak of active tuberculosis was investigated in a 
long term care facility in Aroostook county. 
• Vibriosis cases were reported at higher numbers than in the past. As in 2012, the 
majority of cases had exposures to Maine seafood; however no outbreaks were 
discovered. 
• Campylobacteriosis cases continued to increase with no known reason for the increase.  
• Pertussis continued to be reported in higher than expected numbers compared to five 
years ago; though fewer cases were reported in 2013 than in 2012. 
• The first case of Chikungunya virus, transmitted by mosquitoes, was reported in a Maine 
resident who traveled to the Philippines.  
• Sexually transmitted diseases continued to disproportionately affect young people with 
41% of gonorrhea and 68% of chlamydia cases reported in the 15-24 year age group. 
State sponsored testing programs targeted testing for females in this age group. 
• Fewer animals tested positive for rabies in 2013; only 50 animals were positive 
compared to 91 in 2012. Maine has not had a human case of rabies since 1937. 
• The numbers of newly reported cases of chronic hepatitis C infections increased from 
1,214 in 2012 to 1,265 in 2013. 
• Maine CDC investigated multiple outbreaks of Clostridium difficile in long term care 
facilities. 
• Diseases associated with international travel (such as malaria and shigellosis) occurred 
in Maine residents in 2013. Reports of malaria doubled in 2013 compared to 2012. As 
international travel becomes more common and residents visit areas with endemic 
infectious diseases, there is a need to emphasize preventive strategies among travelers. 
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The History of Public Health Surveillance 
The responsibility of government to control and prevent disease dates back hundreds of years.  
Government responsibility was exercised during the epidemics of plague, syphilis, and smallpox 
in the Middle Ages to identify possible sources of disease, isolate infectious cases, and 
quarantine their contacts to prevent further spread of infection.  Illness was monitored, 
regulations were enacted to prevent pollution of streets and public water supplies, and 
instructions issued for appropriate methods of burial and food handling.  
 
Infectious disease surveillance in the United States began soon after the colonies were 
established.  In 1741, Rhode Island passed legislation requiring tavern keepers to report 
contagious disease among their patrons. Two years later, Rhode Island enacted legislation 
requiring the reporting of smallpox, yellow fever, and cholera. National disease surveillance 
began in 1850, when mortality statistics were first published by the federal government based 
on the decennial census.  The legal requirement to collect national morbidity data in the United 
States was initiated in 1878 when Congress authorized the US Public Health Service to collect 
reports of the occurrence of diseases that require quarantine including cholera, plague, 
smallpox, and yellow fever.   
 
In 1885, the Maine State Board of Health was created and consisted of six members appointed 
by the Governor.  Disease reporting for a select few diseases was conducted by the Maine 
Board of Health.  In 1917 the Board was replaced by the Maine Department of Health.  
 
Overview of Public Health Surveillance 
Seventy-one infectious diseases are reportable in Maine with 55 considered nationally 
reportable.  The list of reportable infectious diseases in Maine changes periodically. The last 
update was in 2008.  Diseases may be added to the list as new pathogens emerge or when a 
previously recognized pathogen becomes more important.  Some diseases may be removed 
from the list as their incidence or importance declines.  While modern advances in sanitation, 
personal hygiene and immunizations provide greater control and prevention of some diseases, 
other infectious diseases continue to thrive and still other yet-to-be-identified infectious disease 
entities are constantly emerging. Vaccine preventable disease are re-emerging in some parts of 
the world due to decreasing vaccination coverage among children.  
 
The Maine Department of Health and Human Services (DHHS) Center for Disease Control and 
Prevention (Maine CDC) works with healthcare providers and laboratorians to gather infectious 
disease information, analyze it, and provide reports in a timely manner. Surveillance data assist 
us in identifying events that require immediate public health action, such as disease outbreaks 
and emerging diseases; identifying populations at higher risk of infection; monitoring trends in 
the burden of disease; guiding the planning, implementation and evaluation of disease 
prevention and treatment programs; and informing public policy. 
  
The public health "patient" is the community, and information about community health can be 
useful to the clinician providing care to the individual.  Partnership between public health 
professionals, healthcare providers, and clinical laboratories is critical to assure accurate, 
representative and timely information for all.  
 
Disease Reporting in Maine  
Healthcare providers, medical laboratories, healthcare facilities, administrators, health officers, 
veterinarians and others are required to report notifiable diseases to the Maine CDC (Appendix 
H).  Diseases that require specific and immediate public health response or are possible 
indicators of bioterrorism are to be reported immediately by telephone.  The remainder of 
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notifiable conditions are to be reported within 24 or 48 hours of recognition or strong suspicion 
of disease. 
 
Disease reports may be made by electronic laboratory report (ELR), telephone or fax to the 
Maine CDC 24 hours a day, 7 days a week. The reporting numbers are toll free: telephone 1-
800-821-5821 and fax 1-800-293-7534.  An epidemiologist is on call 24 hours a day, 7 days a 
week to respond to infectious disease emergencies.  Disease reports may also be mailed to the 
Division of Infectious Disease, 286 Water Street, 8th Floor, 11 State House Station, Augusta, 
Maine 04333-0011.  Non-confidential reports or requests for consultation can be sent by email 
to disease.reporting@maine.gov.  
 
Infectious disease conditions reportable in Maine, the Rules for the Control of Notifiable 
Conditions and current information regarding infectious disease incidence in Maine are available 
on the Maine CDC website (http://www.maine.gov/dhhs/mecdc/infectious-disease/epi/disease-
reporting/index.shtml).  
 
The Maine Health and Environmental Testing Laboratory (HETL) tests for most reportable 
conditions. Certain organisms are required to be sent to HETL for confirmatory testing and the 
rules for isolate submission can be found on the notifiable conditions list. Information on the 
testing performed at HETL is available at www.mainepublichealth.gov/lab. 
 
Purpose of Report 
The Reportable Infectious Diseases in Maine 2013 Summary provides descriptive epidemiology 
of reportable infectious diseases in Maine and serves as a document of public health 
surveillance data. The report allows public health officials to comprehend the burden of 
reportable infectious diseases in Maine.  For example, surveillance data has demonstrated the 
spread of deer ticks and Lyme disease within Maine.   
 
Methods 
The data in this report are based on case definitions developed by the Council of State and 
Territorial Epidemiologists (CSTE) and adopted by federal CDC and the Maine CDC. Case 
definitions may change from year to year. The case definitions used to classify 2013 data are 
available at http://www.cdc.gov/osels/ph_surveillance/nndss/PHS/infdis2011.htm. Cases 
meeting the confirmed or probable case definitions are presented in the annual report.  
 
Tables in the introduction section include all confirmed and probable cases reported to the 
federal CDC for their publications, unless otherwise noted.  Rates are calculated by dividing the 
number of cases by the appropriate population from the yearly U.S. Census estimates and 
multiplying by 100,000. Charts and graphs may not include the total number of cases due to 
missing information on patient characteristics, such as county of residence, symptom onset 
date, age and gender. 
 
Over time additional information may necessitate review and updates of historical data. The 
most current published report will have the updated historical counts and trends for all diseases. 
 
More detailed information about each disease condition, including educational materials for 
healthcare providers and the general public, is available at www.mainepublichealth.gov. 
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Counts of Selected Reportable Disease by Year, Maine, 2004 – 2013* 
 
Disease 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Anaplasmosis 1 5 10 9 17 15 17 26 52 94 
Babesiosis 5 11 9 11 11 3 5 9 10 36 
Campylobacteriosis 141 159 137 149 151 171 148 195 189 228 
Chlamydia  2120 2253 2304 2543 2594 2443 2586 3094 3413 3439 
Cryptosporidiosis 22 30 52 56 46 67 93 51 58 35 
Dengue Fever NR NR NR NR NR 3 6 0 0 1 
Ehrlichia chaffeensis 0 1 4 3 1 1 4 1 3 3 
Giardiasis 155 202 192 197 188 223 223 171 169 218 
Gonorrhea  214 142 137 118 96 143 162 272 456 246 
Group A Streptococcal 
Disease (invasive) 
16 14 19 28 28 21 47 43 37 37 
Group B Streptococcal 
Disease, Infant (invasive) 
1 3 1 1 6 2 8 2 5 2 
H. Influenzae (invasive) 15 12 21 13 21 21 13 26 23 25 
Hemolytic uremic syndrome  2 0 6 1 1 2 1 2 2 2 
Hepatitis A, acute 16 9 8 5 18 1 7 6 9 10 
Hepatitis B, acute 11 14 26 19 15 15 13 8 9 11 
Hepatitis B, chronic NA NA NA 139 142 125 101 105 105 107 
Hepatitis C, acute 0 0 2 1 3 2 2 12 8 8 
Hepatitis C, chronic NA NA NA NA NA NA 1142 1184 1214 1265 
HIV Infection  46 59 62 64 46 56 59 54 48 39 
Legionellosis 1 7 11 9 11 10 12 18 18 23 
Listeriosis 8 3 6 5 5 4 1 4 5 4 
Lyme disease 224 245 338 530 909 976 752 1012 1113 1376 
Malaria 6 5 4 8 1 2 6 6 5 10 
Meningococcal disease 12 2 9 8 6 4 5 5 3 4 
MRSA, invasive NR NR NR NR 47 122 90 121 116 130 
Mumps 0 2 0 24 5 6 2 2 0 1 
Pertussis 195 55 174 83 49 80 53 205 737 332 
Rabies, animal 69 61 127 86 70 63 67 66 91 50 
Salmonellosis 108 163 161 138 159 121 133 134 161 131 
Shiga toxin producing E. coli 18 29 49 41 26 19 21 28 20 27 
Shigellosis 13 15 10 14 20 5 8 32 7 5 
Streptococcus pneumoniae, 
invasive 
NA NA NA NA NA NA 151 136 102 121 
Streptococcus pneumoniae 
(drug resistant invasive) 
4 8 12 13 18 23 30 32 20 31 
Streptococcal Toxic Shock 
Syndrome 
1 0 0 1 0 0 21 12 10 16 
Syphilis (early)  2 3 16 14 20 14 39 20 19 16 
Tuberculosis  20 17 16 19 9 9 8 9 17 15 
Varicella (Chickenpox) 363 318 238 366 269 235 247 226 258 140 
Vibriosis 4 2 5 0 3 4 5 4 10 9 
*Counts may change from year to year. 
NR = not reportable; NA = not available 
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Rates of Selected Reportable Disease by Year, Maine, 2004 – 2013* 
Disease 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Anaplasmosis 0.1 0.4 0.8 0.7 1.3 1.1 1.3 2.0 3.9 7.1 
Babesiosis 0.4 0.8 0.7 0.8 0.8 0.2 0.4 0.7 0.8 2.7 
Campylobacteriosis 10.7 12.1 10.4 11.3 11.5 13.0 11.3 14.7 14.2 17.2 
Chlamydia 161.4 170.9 174.3 192.9 197.0 185.3 197.0 233.0 256.8 258.9 
Cryptosporidiosis 1.7 2.3 3.9 4.3 3.5 5.1 7.1 3.8 4.4 2.6 
Dengue Fever NR NR NR NR NR 0.2 0.5 0.0 0.0 0.1 
Ehrlichia chaffeensis 0.0 0.0 0.3 0.2 0.1 0.1 0.3 0.1 0.2 0.2 
Giardiasis 11.8 15.3 14.5 15.0 14.3 16.9 17.0 12.9 12.7 16.4 
Gonorrhea 16.3 10.8 10.4 9.0 7.3 10.9 12.3 20.5 34.3 18.5 
Group A Streptococcal 
Disease (invasive) 
1.2 1.1 1.4 2.1 2.1 1.6 3.6 3.2 2.8 2.8 
H. Influenzae (invasive) 1.1 0.9 1.6 1.0 1.6 1.6 1.0 2.0 1.7 1.9 
Hemolytic uremic syndrome  0.2 0.0 0.5 0.1 0.1 0.2 0.1 0.2 0.2 0.2 
Hepatitis A, acute 1.2 0.7 0.6 0.4 1.4 0.1 0.5 0.5 0.7 0.8 
Hepatitis B, acute 0.8 1.1 2.0 1.4 1.1 1.1 1.0 0.6 0.7 0.8 
Hepatitis B, chronic NA NA NA 10.6 10.8 9.5 7.7 7.9 7.9 8.1 
Hepatitis C, acute 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.9 0.6 0.6 
Hepatitis C, chronic NA NA NA NA NA NA 87.0 89.1 91.3 95.2 
HIV Infection 3.5 4.4 4.3 3.9 3.5 4.3 4.3 4.1 3.6 2.9 
Legionellosis 0.1 0.5 0.8 0.7 0.8 0.8 0.9 1.4 1.4 1.7 
Listeriosis 0.6 0.2 0.5 0.4 0.4 0.3 0.1 0.3 0.4 0.3 
Lyme disease 17.1 18.6 25.6 40.2 69.1 74.0 57.3 76.2 83.7 103.6 
Malaria 0.5 0.4 0.3 0.6 0.1 0.2 0.5 0.5 0.4 0.8 
Meningococcal disease 0.9 0.2 0.7 0.6 0.5 0.3 0.4 0.4 0.2 0.3 
MRSA, invasive NR NR NR NR 3.6 9.3 6.9 9.1 8.7 9.8 
Mumps 0.0 0.2 0.0 1.8 0.4 0.5 0.2 0.2 0.0 0.1 
Pertussis 14.8 4.2 13.2 6.3 3.7 6.1 4.0 15.4 55.5 25.0 
Rabies, animal NA NA NA NA NA NA NA NA NA NA 
Salmonellosis 8.2 12.4 12.2 10.5 12.1 9.2 10.1 10.1 12.1 9.9 
Shiga toxin producing E. coli 1.4 2.2 3.7 3.1 2.0 1.4 1.6 2.1 1.5 2.0 
Shigellosis 1.0 1.1 0.8 1.1 1.5 0.4 0.6 2.4 0.5 0.4 
Streptococcus pneumoniae, 
invasive 
NA NA NA NA NA NA 9.9 10.2 7.7 9.1 
Streptococcus pneumoniae 
(drug resistant invasive) 
0.3 0.6 0.9 
 
1.0 1.4 1.7 2.3 2.4 1.5 2.3 
Syphilis (early) 0.2 0.2 1.2 0.7 1.5 1.1 2.9 1.5 1.4 1.2 
Tuberculosis 1.5 1.3 1.2 1.4 0.7 0.7 0.6 0.7 1.3 1.1 
Varicella (Chickenpox) 27.6 24.1 18.0 27.8 20.4 17.8 18.8 17.0 19.4 10.5 
Vibriosis 0.3 0.2 0.4 0.0 0.2 0.3 0.4 0.3 0.8 0.7 
*Rates may change from year to year. 
NR = not reportable 
NA = not available
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Reportable Diseases with Historically Small Numbers of Cases, Maine, 2004 - 2013 
 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 10 year total 
Anthrax 0 0 0 0 0 0 0 0 0 0 0 
Botulism, foodborne 1 0 0 0 0 0 0 0 0 0 1 
Brucellosis 0 0 0 0 0 0 2 0 0 0 2 
Creutzfeld-Jacob disease (<55 yo) 0 0 0 0 0 1 0 0 0 0 1 
Cyclosporiasis 1 0 0 0 0 0 1 0 0 0 2 
Diphtheria 0 0 0 0 0 0 0 0 0 0 0 
Eastern Equine Encephalitis (EEE) 0 0 0 0 0 0 0 0 0 0 0 
Ehrlichiosis, ewingii 0 0 0 0 0 0 0 0 0 1 1 
Hantavirus Pulmonary Syndrome 0 0 0 0 0 0 0 1 0 0 1 
Measles 0 0 0 0 0 0 0 0 0 0 0 
Plague 0 0 0 0 0 0 0 0 0 0 0 
Psittacosis 1 0 0 0 0 0 0 0 0 0 1 
Poliomyelitis 0 0 0 0 0 0 0 0 0 0 0 
Powassan Virus 1 0 0 0 0 0 0 0 0 1 2 
Q Fever 0 2 4 7 0 0 0 2 0 0 15 
Rubella 0 0 0 0 0 0 0 0 0 0 0 
Rocky Mountain Spotted Fever^ NR NR NR NR 1 5 2 1 3 2 14 
Severe Acute Respiratory 
Syndrome (SARS) 0 0 0 0 0 0 0 0 0 0 0 
Smallpox 0 0 0 0 0 0 0 0 0 0 0 
Tetanus^ 0 0 0 0 0 0 0 0 0 1 1 
Toxoplasmosis 1 0 0 0 0 0 0 0 0 0 1 
Trichinosis 0 0 0 0 0 0 1 1 0 0 2 
Tularemia 0 0 0 0 0 0 0 0 0 0 0 
Typhoid Fever 0 0 1 0 0 0 2 0 0 0 3 
Venezuelan Equine Encephalitis 0 0 0 0 0 0 0 0 0 0 0 
West Nile Virus  0 0 0 0 0 0 0 0 1 0 1 
Yellow Fever 0 0 0 0 0 0 0 0 0 0 0 
NR=Not reportable, ^Reported cases were probable only in 2013,  
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2013 
 Anaplasmosis Babesiosis Campylobacteriosis Cryptosporidiosis Ehrlichia 
chaffeensis 
Giardiasis 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 2 1.9 0 0.0 9 8.4 0 0.0 0 0.0 19 17.7 
Aroostook 1 1.4 0 0.0 16 22.8 0 0.0 0 0.0 8 11.4 
Cumberland 19 6.7 9 3.2 55 19.3 6 2.1 1 0.4 69 24.2 
Franklin 2 6.6 0 0.0 6 8.0 0 0.0 0 0.0 6 19.7 
Hancock 0 0.0 0 0.0 10 18.2 1 1.8 0 0.0 11 20.1 
Kennebec 7 5.8 1 0.8 25 20.6 7 5.8 0 0.0 15 12.4 
Knox 27 68.3 7 17.7 4 10.1 0 0.0 1 2.5 1 2.5 
Lincoln 10 29.3 1 2.9 8 23.5 0 0.0 0 0.0 10 29.3 
Oxford 2 3.5 0 0.0 15 26.2 0 0.0 0 0.0 6 10.5 
Penobscot 0 0.0 1 0.7 18 11.7 9 5.9 0 0.0 12 7.8 
Piscataquis 0 0.0 0 0.0 1 5.8 1 5.8 0 0.0 3 17.5 
Sagadahoc 3 8.6 0 0.0 3 8.6 0 0.0 0 0.0 6 17.1 
Somerset 0 0.0 0 0.0 7 13.5 3 5.8 0 0.0 13 25.1 
Waldo 3 7.7 0 0.0 5 12.8 1 2.6 0 0.0 18 46.2 
Washington 0 0.0 0 0.0 4 12.4 0 0.0 0 0.0 4 12.4 
York 18 9.0 17 8.5 42 21.1 7 3.5 1 0.5 17 8.5 
Maine Total 94 7.1 36 2.7 228 17.2 35 2.6 3 0.2 218 16.4 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2013 
 Haemophilus 
influenzae, invasive 
Hemolytic uremic 
syndrome 
Hepatitis A, 
acute 
Hepatitis B, acute Hepatitis B, 
chronic 
Legionellosis 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 1 0.9 0 0.0 0 0.0 0 0.0 5 4.6 0 0.0 
Aroostook 2 2.9 0 0.0 0 0.0 0 0.0 1 1.4 1 1.4 
Cumberland 10 3.5 0 0.0 5 1.8 6 2.1 58 20.3 5 1.8 
Franklin 0 0.0 0 0.0 0 0.0 0 0.0 1 3.3 1 3.3 
Hancock 0 0.0 0 0.0 0 0.0 0 0.0 2 3.6 3 5.5 
Kennebec 7 5.8 0 0.0 0 0.0 0 0.0 3 2.5 1 0.8 
Knox 0 0.0 0 0.0 0 0.0 0 0.0 3 7.6 1 2.5 
Lincoln 0 0.0 0 0.0 0 0.0 0 0.0 3 8.8 0 0.0 
Oxford 0 0.0 0 0.0 1 1.7 0 0.0 3 5.2 1 1.7 
Penobscot 3 2.0 2 1.3 2 1.3 0 0.0 6 3.9 2 1.3 
Piscataquis 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 5.8 
Sagadahoc 0 0.0 0 0.0 1 2.9 1 2.9 1 2.9 1 2.9 
Somerset 0 0.0 0 0.0 1 1.9 2 3.9 1 1.9 0 0.0 
Waldo 0 0.0 0 0.0 0 0.0 2 5.1 4 10.3 3 7.7 
Washington 0 0.0 0 0.0 0 0.0 0 0.0 2 6.2 0 0.0 
York 2 1.0 0 0.0 0 0.0 0 0.0 14 7.0 3 1.5 
Maine Total 25 1.9 2 0.2 10 0.8 11 0.8 107 8.1 23 1.7 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2013 
 Listeriosis Lyme Disease Malaria* Meningococcal 
invasive disease 
MRSA, invasive Mumps 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 0 0.0 69 64.1 2 1.9 0 0.0 7 6.5 0 0.0 
Aroostook 0 0.0 3 4.3 0 0 0 0.0 8 11.4 0 0.0 
Cumberland 2 0.7 351 123.0 6 2.1 3 1.1 27 9.5 0 0.0 
Franklin 0 0.0 10 32.8 0 0.0 0 0.0 2 6.6 0 0.0 
Hancock 0 0.0 100 182.3 0 0.0 0 0.0 7 12.8 0 0.0 
Kennebec 1 0.8 183 151.0 0 0.0 0 0.0 12 9.9 0 0.0 
Knox 0 0.0 95 240.2 0 0.0 0 0.0 1 2.5 0 0.0 
Lincoln 0 0.0 70 205.4 0 0.0 0 0.0 4 11.7 0 0.0 
Oxford 0 0.0 50 87.3 0 0.0 0 0.0 3 5.2 0 0.0 
Penobscot 0 0.0 39 25.4 0 0.0 1 0.7 20 13.0 1 0.7 
Piscataquis 0 0.0 0 0.0 0 0.0 0 0.0 2 11.7 0 0.0 
Sagadahoc 1 2.9 53 151.4 0 0.0 0 0.0 6 17.1 0 0.0 
Somerset 0 0.0 32 61.9 0 0.0 0 0.0 4 7.7 0 0.0 
Waldo 0 0.0 88 226.0 0 0.0 0 0.0 3 7.7 0 0.0 
Washington 0 0.0 13 40.4 0 0.0 0 0.0 6 18.6 0 0.0 
York 0 0.0 220 110.3 1 0.5 0 0.0 18 9.0 0 0.0 
Maine Total 4 0.3 1376 103.6 10 0.8 4 0.3 130 9.8 1 0.1 
*One unknown county 
13
Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2013 
 Pertussis Rabies, animal Salmonellosis Shiga toxin 
producing E. coli 
Shigellosis 
County No. Rate No. Rate No. Rate No. Rate No. No. 
Androscoggin 35 32.5 1  11 10.2 1 0.9 0 0.0 
Aroostook 6 8.6 0  7 10.0 0 0.0 0 0.0 
Cumberland 42 14.7 8  27 9.5 6 2.1 1 0.4 
Franklin 0 0.0 1  8 26.2 1 3.3 0 0.0 
Hancock 10 18.2 3  3 5.5 1 1.8 0 0.0 
Kennebec 55 45.4 10  16 13.2 4 3.3 1 0.8 
Knox 18 45.5 0  4 10.1 0 0.0 0 0.0 
Lincoln 2 5.9 1  4 11.7 0 0.0 0 0.0 
Oxford 58 101.3 3  3 5.2 1 1.7 0 0.0 
Penobscot 23 15.0 6  11 7.2 6 3.9 0 0.0 
Piscataquis 10 58.4 1  0 0.0 0          0.0 0 0.0 
Sagadahoc 5 14.3 1  2 5.7 1 2.9 0 0.0 
Somerset 10 19.3 5  7 13.5 0 0.0 0 0.0 
Waldo 20 51.4 3  4 10.3 0 0.0 0 0.0 
Washington 0 0.0 1  1 3.1 1 3.1 0 0.0 
York 38 19.1 6  23             11.5 5 2.5 3 1.5 
Maine Total 332 25.0 50  131 9.9 27 2.0 5 0.4 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2013 
 Streptococcus, 
invasive Group A 
Streptococcus 
pneumoniae, invasive 
Tuberculosis Varicella 
(Chickenpox) 
Vibriosis 
County No. Rate No. Rate No. Rate No. Rate No. No. 
Androscoggin 3 2.8 16 14.9 2 1.9 5 4.6 0 0.0 
Aroostook 2 2.9 7 10.0 3 4.3 5 7.1 0 0.0 
Cumberland 5 1.8 17 6.0 3 1.1 45 15.8 2 0.7 
Franklin 0 0.0 1 3.3 1 3.3 2 6.6 0 0.0 
Hancock 0 0.0 6 10.9 0 0.0 10 18.2 1 1.8 
Kennebec 3 2.5 18 14.9 0 0.0 16 13.2 0 0.0 
Knox 1 2.5 3 7.6 1 2.5 1 2.5 0 0.0 
Lincoln 0 0.0 2 5.9 0 0.0 4 11.7 1 2.9 
Oxford 1 1.7 8 14.0 0 0.0 6 10.5 0 0.0 
Penobscot 9 5.9 13 8.5 2 1.3 5 3.3 0 0.0 
Piscataquis 1 5.8 3 17.5 0 0.0 0 0.0 0 0.0 
Sagadahoc 0 0.0 4 11.4 1 2.9 0 0.0 0 0.0 
Somerset 3 5.8 3 5.8 0 0.0 9 17.4 1 1.9 
Waldo 2 5.1 1 2.6 0 0.0 5 12.8 0 0.0 
Washington 1 3.1 5 15.5 0 0.0 5 15.5 1 3.1 
York 6 3.0 14 7.0 2 1.0 22 11.0 3 1.5 
Maine Total 37 2.8 121 9.1 15 1.1 140 10.5 9 0.7 
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Reportable HIV/STDs, Number of Cases and Rate per 100,000 Persons by County, Maine, 2013 
 Chlamydia Gonorrhea Syphilis, Primary and 
Secondary 
HIV 
County No. Rate No. Rate No. Rate No. Rate 
Androscoggin 504 468.4 91 84.6 2 1.9 8 7.4 
Aroostook 114 162.7 4 5.7 0 0.0 1 1.4 
Cumberland 793 277.8 65 22.8 7 2.5 18 6.3 
Franklin 83 272.2 1 3.3 0 0.0 1 3.3 
Hancock 94 171.4 4 7.3 2 3.6 1 1.8 
Kennebec 297 245.1 10 8.3 2 1.7 3 2.5 
Knox 67 169.4 7 17.7 0 0.0 0 0.0 
Lincoln 55 161.3 4 11.7 0 0.0 0 0.0 
Oxford 127 221.7 5 8.7 0 0.0 0 0.0 
Penobscot 450 293.4 17 11.1 1 0.7 0 0.0 
Piscataquis 26 151.8 0 0.0 0 0.0 0 0.0 
Sagadahoc 78 222.8 2 5.7 0 0.0 0 0.0 
Somerset 129 249.5 5 9.7 0 0.0 1 1.9 
Waldo 77 197.7 4 10.3 0 0.0 0 0.0 
Washington 74 229.9 4 12.4 0 0.0 0 0.0 
York 471 236.2 23 11.5 2 1.0 6 3.0 
Maine Total 3439 258.9 246 18.5 16 1.2 39 2.9 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District*, Maine, 2013 
Condition Aroostook Central Cumberland Downeast Mid Coast 
No. Rate No. Rate No. Rate No. Rate No. Rate 
Anaplasmosis 1 1.4 7 4.0 19 6.7 0 0.0 43 29.1 
Babesiosis 0 0.0 1 0.6 9 3.2 0 0.0 8 5.4 
Campylobacteriosis 16 22.8 32 18.5 55 19.3 14 16.1 20 13.6 
Chlamydia 114 162.7 426 246.4 793 277.8 168 193.0 277 187.7 
Cryptosporidiosis 0 0.0 10 5.8 6 2.1 1 1.1 1 0.7 
Ehrlichia chaffeensis 0 0.0 0 0.0 1 0.4 0 0.0 1 0.7 
Giardiasis 8 11.4 28 16.2 69 24.2 15 17.2 35 23.7 
Gonorrhea 4 5.7 15 8.7 65 22.8 8 9.2 17 11.5 
Haemophilus influenzae, invasive 2 2.9 7 4.0 10 3.5 0 0.0 0 0.0 
Hemolytic uremic syndrome 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
HIV 1 1.4 4 2.3 18 6.3 1 1.1 0 0.0 
Hepatitis A 0 0.0 1 0.6 5 1.8 0 0.0 1 0.7 
Hepatitis B, acute 0 0.0 2 1.2 6 2.1 0 0.0 3 2.0 
Hepatitis B, chronic 1 1.4 4 2.3 58 20.3 4 4.6 11 7.5 
Legionellosis 1 1.4 1 0.6 5 1.8 3 3.4 5 3.4 
Listeriosis 0 0.0 1 0.6 2 0.7 0 0.0 1 0.7 
 
  
*See map in Appendix I for location of districts 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District*, Maine, 2013 
Condition Penquis Western York State 
No. Rate No. Rate No. Rate No. Rate 
Anaplasmosis 0 0.0 6 3.1 18 9.0 94 7.1 
Babesiosis 1 0.6 0 0.0 17 8.5 36 2.7 
Campylobacteriosis 19 11.1 30 15.4 42 21.1 228 17.2 
Chlamydia 476 279.2 714 365.4 471 236.2 3439 258.9 
Cryptosporidosis 10 5.9 0 0.0 7 3.5 35 2.6 
Ehrlichia chaffeensis 0 0.0 0 0.0 1 0.5 3 0.2 
Giardiasis 15 8.8 31 15.9 17 8.5 218 16.4 
Gonorrhea 17 10.0 97 49.6 23 11.5 246 18.5 
Haemophilus influenzae, invasvie 3 1.8 1 0.5 2 1.0 25 1.9 
Hemolytic uremic syndrome 2 1.2 0 0.0 0 0.0 2 0.2 
HIV 0 0.0 9 4.6 6 3.0 39 2.9 
Hepatitis A 2 1.2 1 0.5 0 0.0 10 0.8 
Hepatitis B, acute 0 0.0 0 0.0 0 0.0 11 0.8 
Hepatitis B, chronic 6 3.5 9 4.6 14 7.0 107 8.1 
Legionellosis 3 1.8 2 1.0 3 1.5 23 1.7 
Listeriosis 0 0.0 0 0.0 0 0.0 4 0.3 
*See map in Appendix I for location of districts 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District*, Maine, 2013 
Condition Aroostook Central Cumberland Downeast Mid Coast 
No. Rate No. Rate No. Rate No. Rate No. Rate 
Lyme Disease 3 4.3 215 124.4 351 123.0 113 129.8 306 207.3 
Meningococcal invasive disease 0 0.0 0 0.0 3 1.1 0 0.0 0 0.0 
MRSA, invasive 8 11.4 16 9.3 27 9.5 13 14.9 14 9.5 
Mumps 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
Pertussis 6 8.6 65 37.6 42 14.7 10 11.5 45 30.5 
Rabies, animal 0  16  8  4  5  
Salmonellosis 7 10.0 23 13.3 27 9.5 4 4.6 14 9.5 
Shiga toxin producing E. coli 0 0.0 4 2.3 6 2.1 2 2.3 1 0.7 
Shigellosis 0 0.0 1 0.6 1 0.4 0 0.0 0 0.0 
Streptococcus, invasive Group A 2 2.9 6 3.5 5 1.8 1 1.1 3 2.0 
Streptococcus pneumoniae, 
invasive  7 10.0 21 12.1 17 6.0 11 12.6 10 6.8 
Syphilis 0 0.0 2 1.2 7 2.5 2 2.3 0 0.0 
Tuberculosis 3 4.3 0 0.0 3 1.1 0 0.0 2 1.4 
Varicella (chickenpox) 5 7.1 25 14.5 45 15.8 15 17.2 10 6.8 
Vibriosis 0 0.0 1 0.6 2 0.7 2 2.3 1 0.7 
*See map in Appendix I for location of districts 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District*, Maine, 2013 
Condition Penquis Western York State 
No. Rate No. Rate No. Rate No. Rate 
Lyme Disease 39 22.9 129 66.0 220 110.3 1376 103.6 
Meningococcal invasive disease 1 0.6 0 0.0 0 0.0 4 0.3 
MRSA, invasive 22 12.9 12 6.1 18 9.0 130 9.8 
Mumps 1 0.6 0 0.0 0 0.0 1 0.1 
Pertussis 33 19.4 93 47.6 38 19.1 332 25.0 
Rabies, animal 6  5  6  50  
Salmonellosis 11 6.5 22 11.3 23 11.5 131 9.9 
Shiga toxin producing E. coli 6 3.5 3 1.5 5 2.5 27 2.0 
Shigellosis 0 0.0 0 0.0 3 1.5 5 0.4 
Streptococcus, invasive Group A 10 5.9 4 2.0 6 3.0 37 2.8 
Streptococcus pneumoniae, 
invasive  16 9.4 25 12.8 14 7.0 121 9.1 
Syphilis  1 0.6 2 1.0 2 1.0 16 1.2 
Tuberculosis 2 1.2 3 1.5 2 1.0 15 1.1 
Varicella 5 2.9 13 6.7 22 11.0 140 10.5 
Vibriosis 0 0.0 0 0.0 3 1.5 9 0.7 
*See map in Appendix I for location of districts 
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Anaplasmosis 
2013 Case Total 94 
Maine Rate 7.1 per 100,000 
U.S. rate (2012) 0.8 per 100,000 
Anaplasmosis Incidence, Maine and US, 
2009-2013
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Anaplasmosis is a disease caused by the 
bacterium Anaplasma phagocytophili-
um.    
 
Signs and symptoms of anaplasmosis 
include:  fever, headache, malaise, and 
body aches.  Anaplasmosis is transmit-
ted to a person by the bite of an infected 
deer tick (Ixodes scapularis), one of the 
most common ticks in Maine. 
 
 94 cases represent an  increase from 
52 cases in 2012 
 The 2008-2012 median number of 
cases per year was 17 
 Median age was 60 years 
 Age range was 20 to 91 years 
 Cases were 37% female and 63% 
male 
 Greatest number of cases occurred 
during the summer and  fall months 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting            
anaplasmosis. Using EPA approved  
repellents such as DEET on skin or    
permethrin on clothing is a good way to 
protect against tick bites. Always follow 
the instructions on the label when     
applying repellent products. If an      
engorged tick is found, it should be 
safely removed and saved for           
identification. Monitor for signs and 
symptoms for 30 days after the tick bite. 
 
For more information about submitting 
a tick for identification only (not test-
ing) visit http://extension.umaine.edu/
ipm/tickid/    
.      
*onset date missing for two cases 
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Babesiosis 
2013 Case Total 36 
Maine Rate 2.7 per 100,000 
U.S. rate (2012) 0.3 per 100,000 
Babesiosis Incidence, Maine, 2009-2013
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Babesiosis is caused by a parasite that 
may be carried by ticks.  Many individ-
uals that get the disease do not have 
symptoms.  Serious symptoms can oc-
cur, especially in persons who are im-
munosuppressed, those without a 
spleen, or people who are co-infected 
with Lyme disease.  Babesiosis may 
also occur after a blood transfusion 
from an infected donor. 
 
Common symptoms include: extreme 
fatigue, aches, fever, chills, sweating, 
dark urine, and possibly anemia.   
 
 36 cases represent an increase from  
10 cases in 2012 
 The 2008-2012 median number of 
cases was 9 
 Median age was 63 years 
 Age range was 34 to 86 years 
 Cases were 33% female and 67% 
male 
 Greatest number of cases occurred 
during the summer months 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting babesio-
sis.  Using EPA approved repellents 
such as DEET on skin or permethrin on 
clothing is a good way to protect against 
tick bites. Always follow the instruc-
tions on the label when applying repel-
lent products. If an engorged tick is 
found, it should be safely removed and 
saved for identification. Monitor for 
signs and symptoms for 30 days after 
the tick bite. 
 
For more information about submitting 
a tick for identification only (not test-
ing) visit http://extension.umaine.edu/
ipm/tickid/    
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Campylobacteriosis 
2013 Case Total 228 
Maine Rate 17.2 per 100,000 
U.S. rate (2012) Not reportable 
Campylobacteriosis Incidence, Maine, 
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Campylobacteriosis is one of the most 
common infectious diseases causing 
diarrhea in the United States.  Symp-
toms include: diarrhea, cramping, ab-
dominal pain and fever. Most people 
recover within 5 to 10 days.  
 
Campylobacteriosis is associated with 
handling raw poultry or eating under-
cooked poultry meat, consuming unpas-
teurized milk and other dairy products 
and from exposure to contaminated 
foods. Raw foods, such as vegetables or 
salad, can be contaminated if the same 
cutting board or utensils are used for 
both raw foods and raw poultry items 
and not cleaned between preparations.  
 
 228 cases represent an increase from 
189 cases in 2012 
 The 2008-2012 median number of 
cases was 172   
 Median age was 47 years 
 Age range was 16 days to 94 years 
 Cases were 47% female and 53% 
male 
 Highest rates in Oxford, Lincoln and 
Aroostook counties 
 Greatest number of cases occurred 
during the summer months  
 
To prevent illness, individuals should 
cook poultry and other meats properly, 
avoid consuming untreated water, raw 
milk and milk products, and unpasteur-
ized juice. Wash hands well with soap 
and water after contact with baby poul-
try, pets and other animals. 
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Chlamydia 
2013 Case Total 3,439 
Maine Rate 258.9 per 100,000 
U.S. rate (2012) 456.7 per 100,000 
Chlamydia Incidence, Maine and US, 2009-2013
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Chlamydia is a sexually transmitted dis-
ease (STD) caused by the bacterium 
Chlamydia trachomatis.  Chlamydia is 
known as a “silent” disease, as three 
quarters (75%) of women and half 
(50%) of men infected with chlamydia 
will have no symptoms.  Common 
symptoms for women include vaginal 
discharge or a burning sensation with 
urination and for men include penile 
discharge and burning on urination.  
 
If chlamydia is not treated, the infection  
may cause serious damage to the repro-
ductive system, including infertility.  
Chlamydia can be passed to a child dur-
ing birth.  People with chlamydia can 
more easily contract HIV from someone 
else  or transmit HIV to others if they 
are infected with both.    
   
 Chlamydia is the most frequently 
reported STD in Maine 
 Median age was 22 years 
 Age range was 12 to 66 years 
 68% of infections were in persons 
15-24 years old 
 Cases were 70% female and 30% 
male 
 
Chlamydia can be prevented by the use 
of latex or polyurethane condoms and 
dental dams during anal, vaginal, and 
oral sex. Efforts to prevent the spread of 
chlamydia include prioritized follow up 
activities for new diagnoses  and the 
Infertility Prevention Project, a federal 
CDC sponsored initiative, that targets 
testing and treatment for females 15-24 
years old and their partners.  Currently 
free testing for females 15-24 is availa-
ble at Family Planning and Planned 
Parenthood sites, and at one STD clinic 
in Portland.  
 
 
*unknown age for 8 cases. 
Chlamydia by Month, Maine, 2013 
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Cryptosporidiosis 
2013 Case Total 35 
Maine Rate 2.6 per 100,000 
U.S. rate (2012) 2.5 per 100,000 
Cryptosporidiosis Incidence, Maine and US,
 2009-2013
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Cryptosporidiosis is an infection most 
frequently associated with contaminated 
water or contact with infected animals. 
The disease is caused by a parasite that 
lives in the intestines of animals and 
infected humans.  Feces containing the 
parasite may contaminate the ground or 
water sources.  The parasite may live 
for long periods of time in the environ-
ment due to a protective outer covering. 
It is resistant to many chlorine-based 
disinfectants, increasing the risk of 
transmission in swimming pools and 
waterparks. 
 
Symptoms include: diarrhea, abdominal 
cramping, malaise and vomiting. 
 
 35 cases represent a decrease from 58 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 58 
 Median age was 24 years 
 Age range was 1 year to 80 years 
 Cases were 46% female and 54% 
male 
 Highest incidence was in Penobscot, 
Kennebec, Piscataquis and Somerset 
counties 
 
Preventive measures include consuming 
pasteurized milk and dairy products, 
practicing good hand hygiene around 
farm animals and discouraging  persons 
of all ages from swimming when they 
have diarrheal illness. 
*onset date missing for one case 
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Giardiasis 
2013 Case Total 218 
Maine Rate 16.4 per 100,000 
U.S. rate (2012) 4.8 per 100,000 
Giardiasis Incidence, Maine and US, 2009-2013
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Giardiasis is sometimes known as 
“beaver fever” because beavers (as well 
as dogs, cats, horses and cows) are ma-
jor reservoirs for the parasite (Giardia 
lamblia) that causes the infection. The 
parasite lives in the intestines of infect-
ed humans and animals and when ex-
pelled through the feces can contami-
nate water and  surfaces. If hikers or 
others drink water without proper treat-
ment they may become infected. Young 
children in child care or pool settings 
who are prone to sucking on toys or 
swallowing water are also at higher risk. 
 
 218 cases represent an increase from 
169 cases in 2012 
 The 2008-2012 median number of 
cases per year was 187 
 Median age was 47 years 
 Age range was 9 days to 89 years 
 Cases were 47% female and 53% 
male 
 Highest incidence was in Waldo, Lin-
coln and Somerset counties 
 Greatest number of cases occurred 
during the late summer  and fall 
months 
 
Individuals can prevent this illness by 
not drinking from untreated water 
sources, such as streams and lakes.  In-
creased attention to proper sanitation 
and hygiene in public water recreational 
facilities can help to reduce the trans-
mission of Giardia. 
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Gonorrhea 
2013 Case Total 246 
Maine Rate 18.5 per 100,000 
U.S. rate (2012) 107.5 per 100,000 
Gonorrhea Incidence, Maine and US, 2009-2013
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Gonorrhea is a sexually transmitted dis-
ease (STD) caused by the bacterium 
Neisseria gonorrhoeae that grows and 
multiplies in warm, moist areas 
(mucous membranes).  Gonorrhea can 
be spread through contact with the vagi-
na, penis, mouth or anus.  Gonorrhea 
can also spread from a mother to her 
baby during childbirth.  Gonorrhea does 
not always cause symptoms.  Men may 
feel a burning sensation while urinating, 
or have  discharge from their penis.  
Women might feel pain with urination, 
or notice discharge from their vagina.   
 
Gonorrhea is dangerous if untreated.  In 
women, gonorrhea is a common cause 
of pelvic inflammatory disease, which 
can lead to chronic pain and infertility.  
In men, gonorrhea can cause epididy-
mitis, causing painful testicles and  in-
fertility.  People infected with HIV are 
more likely to contract gonorrhea and to 
transmit HIV if they are also infected 
with gonorrhea.     
 
 Case total of 246 represents a de-
crease from 456 cases in 2012 
 Median age was 26 years 
 Age range was 14 to 69 years 
 Highest incidence was among per-
sons 20-29 years, with a total of 53% 
of cases, followed by persons 30-39 
years with 23% of cases  
 Cases were 52% female and 48% 
male 
 
Gonorrhea can be prevented by using 
latex or polyurethane condoms and den-
tal dams during anal, vaginal, and oral 
sex. Prevention efforts include treatment 
verification and case investigation activ-
ities, such as partner follow-up for all 
new  infections. State sponsored testing 
through the Infertility Prevention Pro-
ject uses a combination gonorrhea and 
chlamydia test targeting females 15-24 
years old. 
Gonorrhea by Month, Maine, 2013
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Group A Streptococcal 
Disease 
2013 Case Total 37 
Maine Rate 2.8 per 100,000 
U.S. rate (2012) Not reportable 
Invasive GAS Incidence, Maine, 2009-2013
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Group A Streptococcus (GAS) is a bac-
terium often found in the throat and on 
the skin that can cause either no symp-
toms (colonization) or mild symptoms 
such as pharyngitis (strep throat), cellu-
litis (soft tissue infection) or impetigo 
(skin dermatitis).  When the bacteria 
enters deeper tissues and the blood 
stream, GAS can cause severe or life-
threatening conditions. 
 
GAS may lead to Streptococcal Toxic 
Shock Syndrome (STSS), a rapid drop 
in blood pressure that causes organ fail-
ure. Necrotizing fasciitis, a condition 
that progressively destroys skin, fat and 
muscles, can be caused by GAS.   
 
 37 cases represents the same number 
of cases as 2012  
 The 2008-2012 median number of 
cases per year was 37 
 Median age was 60 years 
 Age range was 22 years to 89 years 
 Cases were 38% female and 62% 
male 
 16 (43%) cases were also diagnosed 
with STSS 
 3 GAS cases also diagnosed with 
STSS died 
 
Control and prevention strategies may 
include targeted chemoprophylaxis for 
high risk household contacts of con-
firmed cases, such as those who are 65 
and older or those who have other speci-
fied risk factors (HIV infection, diabe-
tes, malignancy, injecting drug use, or 
cardiac diseases). 
*onset missing for one case 
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Haemophilus influenzae 
2013 Case Total 25 
Maine Rate 1.9 per 100,000 
U.S. rate (2012) 1.1 per 100,000 
Haemophilus influenzae Incidence, Maine and 
US, 2009-2013
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Haemophilus influenzae disease is 
caused by the Haemophilus influenzae 
bacterium.  A specific type called H. 
influenzae serotype B (Hib) was once 
the most common cause of bacterial 
meningitis in children.  Due to wide-
spread use of Hib vaccine, few cases are 
reported in children less than 5 years old 
each year.   
 
The bacteria are spread from person to 
person, through airborne droplets when 
an infected person coughs or sneezes.  
H. influenzae can cause severe illnesses 
such as meningitis, bacteremia, pneu-
monia and septic arthritis. 
 
 25 cases represent an increase from 
23 cases in 2012 
 The 2008-2012 median number of 
cases per year was 21 
 Median age was 71 years 
 Age range was 5 months to 97 years 
 Cases were 52% female and 48% 
male 
 2 cases of Hib (type b) in children 
aged < 5 years were reported 
 
Haemophilus influenzae serotype b 
(Hib) may be prevented in children 
through vaccination.  Vaccination is 
recommended for all children at ages 2, 
4 and 6 months or at 2 and 4 months 
depending on the type of vaccine availa-
ble.  An additional booster dose is given 
at 12-15 months of age with either type 
of vaccine. 
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Hepatitis A 
2013 Case Total 10 
Maine Rate 0.8 per 100,000 
U.S. rate (2012) 0.5 per 100,000 
Hepatitis A Incidence, Maine and US, 2009-2013
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Hepatitis A is a liver disease caused by 
the hepatitis A virus. The virus is spread 
from person to person by fecal-oral 
transmission that involves putting some-
thing in the mouth (such as food, hands 
or water) that has been contaminated by 
a person infected with hepatitis A.  Poor 
handwashing by persons with  hepatitis 
A increases the risk of transmission. 
The virus spreads more easily in areas 
where sanitary conditions and personal 
hygiene practices are poor.  Most infec-
tions result from exposure during inter-
national travel, or contact with a house-
hold member or a sexual partner who 
has hepatitis A. 
 
Onset of symptoms is usually abrupt 
with fever, malaise, anorexia, nausea 
and abdominal discomfort followed by 
jaundice a few days later. Children are 
often asymptomatic. Upon recovery, a 
person is immune to hepatitis A.  
 
 10 cases represent an increase from 9 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 7 
 Median age was 56 years 
 Age range was 12 years to 78 years 
 Cases were 60% female and 40% 
male 
 
Washing hands after using the bath-
room, changing a diaper, or before pre-
paring or eating food can help prevent 
infection. Hepatitis A can also be pre-
vented through vaccination. The two 
dose vaccine series is recommended for 
all children at 12 months of age and for 
persons who are more likely to be ex-
posed to hepatitis A or become serious-
ly ill if they get hepatitis A.  The vac-
cine is also recommended for some 
travelers and for close contacts of newly 
arriving international adoptees. 
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Hepatitis B, acute 
2013 Case Total 11 
Maine Rate 0.8 per 100,000 
U.S. rate (2012) 1.0 per 100,000 
Acute Hepatitis B Incidence, Maine and US, 
2009-2013
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Hepatitis B is a liver disease caused by 
the hepatitis B virus. Acute hepatitis B 
infection occurs within the first six 
months after someone is exposed to the 
virus. In some cases, acute infection can 
lead to chronic infection. The younger 
the age at time of infection, the greater 
the likelihood of progressing to chronic 
hepatitis B infection. 
 
Hepatitis B virus can be transmitted 
through exposure to blood or body flu-
ids from an infected person (needle 
sticks and other sharps exposures, shar-
ing hypodermic syringes for drug injec-
tion), through sexual contact with an 
infected person, or from an infected 
mother to her child during childbirth.  
Sexual transmission is common among 
men who have sex with men.  
 
Symptoms include anorexia, abdominal 
discomfort, nausea and vomiting fol-
lowed by jaundice. Many young chil-
dren and immunosuppressed adults do 
not develop symptoms. 
 
 11 cases represent an increase from 9 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 13 
 Median age was 44 years 
 Age range was 28 to 62 years 
 Cases were 36% female and 64% 
male 
 
Hepatitis B can be prevented by vac-
cination as well as by not sharing nee-
dles and other drug injecting equipment, 
using sterile needles and syringes, and 
using condoms. Hepatitis B can also be 
prevented by not sharing equipment for 
blood glucose monitoring and insulin 
administration. 
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Hepatitis B, chronic 
2013 Case Total 107 
Maine Rate 8.1 per 100,000 
U.S. rate (2012) Not available 
Newly Reported Cases of Chronic 
Hepatitis B, Maine, 2009-2013
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Hepatitis B is a liver disease caused by 
the hepatitis B virus. Chronic hepatitis 
B virus infection occurs when a person 
infected with acute hepatitis B does not 
clear the virus within the first 6 months 
of infection. 
 
Chronic hepatitis B is a serious disease 
that can result in long-term health prob-
lems, such as cirrhosis (scarring) of the 
liver, liver cancer, liver failure, and 
even death. Many people do not have 
symptoms and may not know they are 
infected, but they can still spread the 
disease to others. 
 
Hepatitis B virus can be transmitted 
through exposure to blood and or body 
fluids from an infected person (needle 
sticks and other sharps exposures, shar-
ing hypodermic syringes for drug injec-
tion), through sexual contact with an 
infected person, or from an infected 
mother to her child during childbirth.  
Sexual transmission also occurs among 
men who have sex with men.  
 
 107 cases represent an increase from 
105 cases in 2012 
 Median age was 38 years 
 Age range was 10 to 76 years 
 Cases were 43% female and 57% 
male 
 
Hepatitis B can be prevented through 
testing and vaccination of susceptible 
household and sexual contacts of identi-
fied cases. Transmission can be prevent-
ed by not sharing needles or other drug 
injecting equipment, using sterile nee-
dles and syringes, and using condoms. 
Hepatitis B can also be prevented by not 
sharing equipment for blood glucose 
monitoring and insulin administration. 
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Hepatitis C, acute 
2013 Case Total 8 
Maine Rate 0.6 per 100,000 
U.S. rate (2012) 0.6 per 100,000 
Acute Hepatitis C Incidence, Maine and US, 
2009-2013
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Hepatitis C is a liver disease caused by 
the hepatitis C virus. Acute hepatitis C 
infection occurs within the first six 
months after someone is exposed to the 
virus. Hepatitis C is spread when blood 
from a person infected with hepatitis C 
enters the body of someone who is not 
infected. Many people become infected 
by sharing needles or other injection 
drug equipment. 
 
Persons with acute or newly acquired 
hepatitis C infection are usually asymp-
tomatic or have mild symptoms. Ap-
proximately 20–30% of persons with 
acute infection experience fatigue, ab-
dominal pain, poor appetite, and/or 
jaundice.  The average time period from 
exposure to symptom onset is 4–12 
weeks (range: 2–24 weeks). Other 
symptoms of acute infection include: 
fever, dark urine, clay-colored stool,  
nausea, vomiting, and joint pain. 
 8 cases represent no change from 
2012 
 The 2008-2012 median number of 
cases per year was 3 
 Median age was 32 years 
 Age range was 20 to 53 years 
 Cases were 50% female and 50% 
male. 
 
To prevent acute hepatitis C, do not 
share needles or equipment used to in-
ject drugs. Do not share personal hy-
giene items or sharps, including equip-
ment for blood glucose monitoring and 
insulin administration. Use licensed tat-
tooists and body piercers. Use condoms 
to  reduce the already low risk of sexual 
transmission.  
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Hepatitis C, past or pre-
sent infection 
2013 Case Total 1265 
Maine Rate 95.2 per 100,000 
U.S. rate (2012) N/A 
Newly Reported Cases of Past or Present Hepatitis 
C Infection, Maine, 2009-2013
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Hepatitis C is a liver disease caused by 
the hepatitis C virus. Past or present 
hepatitis C infection is a long-term ill-
ness that occurs when hepatitis C virus 
remains in a person’s body for more 
than 6 months. Over time it can lead to 
serious liver disease. Hepatitis C is 
spread when blood from a person infect-
ed with hepatitis C enters the body of 
someone who is not infected. Many 
people become infected by sharing nee-
dles or other injection drug equipment. 
 
Most people with hepatitis C infection 
do not have any symptoms. In many 
cases, symptoms only appear when liver 
problems develop. Hepatitis C is often 
detected during routine blood tests to 
measure liver function and liver enzyme 
levels.  
 
 1265 cases represents an  
    increase from 1,214  cases in 2012 
Median age was 37 years 
 Age range was 1 to 93 years 
 Cases were 39% female and 61% 
male 
 
People with past or present hepatitis C 
infection should be monitored regularly 
by an experienced  healthcare provider. 
They should avoid alcohol and  check 
with a health professional before taking 
any prescription pills, supplements, or 
over-the-counter medications, as these 
can potentially damage the liver. Vac-
cination against hepatitis A and hepatitis 
B is also recommended. 
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Newly Reported Cases of Past or Present 
Hepatitis C Infection by Month of Report, Maine, 
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*Gender unknown for one case. 
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HIV* 
2013 Case Total 39 
Maine Rate 2.9 per 100,000 
U.S. rate (2011) 19.1 per 100,000 
Newly Identified HIV Diagnoses, Maine and US, 
2009-2013
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Human immunodeficiency virus (HIV) 
is a virus that is responsible for HIV 
disease and acquired immuno-
deficiency syndrome (AIDS). AIDS 
typically presents as the late clinical 
stage of HIV infection. HIV is transmit-
ted  from person to person through un-
protected penile-vaginal or penile–anal 
intercourse with an infected person; the 
use of HIV contaminated needles and 
syringes; from infected mother to infant 
during pregnancy, delivery, or breast-
feeding; and transfusion of infected 
blood or its components. In Maine, the 
most common mode of HIV transmis-
sion is through unprotected penile-anal 
intercourse among men.  
 
 Case total of 39 represents a decrease 
from 48 cases in 2012  
 The 2009-2013 median number of 
cases per year was 54 
 Age range was 9 months to 60 years  
 Majority of cases were male (69%) 
 46% of cases reported risk factor of 
males who have sex with other males 
  
HIV transmission can be prevented by 
the use of latex or polyurethane con-
doms during anal and vaginal sex.  It is 
equally important to always use clean 
needles and injection equipment when 
injecting any substance.  HIV testing, 
counseling, and referral services are 
offered by various agencies and pro-
grams dedicated to HIV prevention and 
treatment in Maine.   
*Includes all newly identified HIV infections, including those simultaneously diagnosed as new AIDS cases.  
Mode of Transmission New  
Diagnoses 
Men who have sex with men (MSM) 18 
Injection drug users (IDU) 2 
MSM and IDU 0 
Heterosexual contact with at-risk partners 3 
Heterosexual, no at-risk partners disclosed 12 
Undetermined 3 
Received contaminated  blood products 0 
Child born to mother with HIV 1 
% of  
Cases 
46% 
5% 
0% 
8% 
31% 
8% 
0% 
3% 
Reported Transmission Risk Factors Among Persons  
Diagnosed with HIV, 2013 
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Legionellosis 
2013 Case Total 23 
Maine Rate 1.7 per 100,000 
U.S. rate (2012) 1.2 per 100,000 
Legionellosis Incidence, Maine and US, 
2009-2013
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Legionellosis (or Legionnaire’s disease) 
is a serious and sometimes fatal form of 
pneumonia. Legionella bacteria are 
widespread in natural, industrial and 
recreational water sources.  The bacteria 
grow best in warm, stagnant water.  
They can be found in creeks and ponds, 
hot and cold water taps, hot water tanks, 
water cooling towers, and condensers of 
large air-conditioning systems.  People 
get legionellosis when they breathe in a 
mist or vapor that is contaminated with 
the bacteria.  Persons at high risk of get-
ting legionellosis include those who are 
middle aged or older, smoke, have 
chronic lung disease, or weakened im-
mune systems due to cancer, kidney 
failure, diabetes, or HIV infection. 
 
Symptoms include: high fever, chills, 
muscle aches, headaches, cough, and 
pneumonia.  Legionellosis is treatable 
with antibiotics.  
 
 23 cases represent an increase from 
18 cases in 2012 
 The 2008-2012 median number of 
cases per year was 12 
 Median age was 56 years 
 Age range was 42 to 82 years 
 Cases were 35% female and 65% 
male 
 
Prevention depends on good mainte-
nance of possible water sources of in-
fection (water tanks, water systems, 
fountains, etc.). This includes regular 
cleaning, disinfecting, and applying  
other physical (temperature) or chemi-
cal measures to minimize growth.  Ap-
plying such controls at hospitals, indus-
trial sites, hotels, and recreation centers 
will reduce the risk of water contamina-
tion. 
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Listeriosis 
2013 Case Total 4 
Maine Rate 0.3 per 100,000 
U.S. rate (2012) 0.2 per 100,000 
Listeriosis Incidence, Maine and US, 2009-2013
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Listeriosis is a bacterial illness, caused 
by Listeria monocytogenes. Infection 
may cause sepsis and meningitis.  Lis-
teriosis is frequently linked to ready-to-
eat meats (such as paté and refrigerated 
smoked seafood), deli meats, soft chees-
es and raw milk. Pregnant women are at 
highest risk for severe outcomes as an 
infection  acquired during pregnancy 
can be transmitted to the fetus.  Also at 
risk are the elderly and individuals with 
significant health conditions like cancer, 
diabetes, liver disease, immune system 
problems, or multiple medical condi-
tions.  
 
Symptoms include: fever, headache, 
nausea, fatigue and disorientation.  Lis-
teriosis may cause spontaneous abor-
tion.  
 
 4 cases represent a decrease from 5 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 4  
 Median age was 73 years 
 Age range was 65 to 78 years 
 All 4 cases were hospitalized 
 
Listeria bacteria are able to multiply in 
contaminated foods even during refrig-
eration.  Poultry or meat (including hot 
dogs) should not be consumed without 
following proper cooking instructions. 
Raw milk or foods made from raw milk 
should be avoided.  Pregnant women 
and people with weakened immune sys-
tems should avoid eating such foods as 
ready-to-eat meats, hot dogs, soft chees-
es, and refrigerated smoked seafood. 
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Lyme Disease 
2013 Case Total 1,376 
Maine Rate 103.6 per 100,000 
U.S. Rate (2012) 9.8 per 100,000 
Lyme Disease Incidence, Maine and US, 
2009-2013
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Lyme disease, Maine’s most common 
vectorborne disease in humans, is 
caused by the bacterium Borrelia 
burgdorferi. The disease is transmitted 
via the bite of an infected deer tick 
(Ixodes scapularis) and symptoms  gen-
erally appear between 3 and 30 days 
after the initial bite. Early symptoms 
include: a characteristic “bulls eye” 
rash, fever, headache, joint and muscle 
pain, and fatigue. Disseminated symp-
toms include: arthritis, Bell’s palsy and 
other cranial nerve palsies, meningitis, 
and carditis.  
 
 1,376 cases represent an increase 
from 1,113 cases in 2012 
 The 2008-2012 median number of 
cases per year was 976 
 Median age was 50 years 
 Age range was 25 days  to 89 years 
 Cases were 43% female and 57% 
male 
 Cases were highest in Cumberland 
(26%), York (16%), and Kennebec 
(13%) counties 
 
Although there is no vaccine for Lyme 
disease, risk can be greatly reduced by 
avoiding tick habitats, using EPA ap-
proved repellents (such as DEET), 
wearing long sleeves and pants, and 
checking for ticks after spending time in 
tick habitat. Landscape management 
and control of deer herds can also allow 
communities to better protect residents 
from Lyme disease. 
 
For more information about submitting 
a tick for identification (not testing for 
Lyme disease) visit http://
extension.umaine.edu/ipm/tickid/.    
Lyme Disease by Month of Report, Maine, 2013
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Meningococcal Disease 
2013 Case Total 4 
Maine Rate 0.3 per 100,000 
U.S. rate (2012) 0.2 per 100,000 
Meningococcal Disease Incidence, Maine and 
US, 2009-2013
0
0.1
0.2
0.3
0.4
0.5
2009 2010 2011 2012 2013
Year
C
as
es
 p
er
 1
00
,0
00
Maine US
Meningococcal disease is an infection 
caused by Neisseria meningitidis, a 
gram-negative diplococcus bacterium. 
Meningococcal disease presents most 
commonly as meningitis and/or menin-
gococcemia that may progress rapidly to 
purpura fulminans, shock and death. 
Transmission of meningococcal disease 
most often occurs through direct contact 
with respiratory secretions from the 
nose or throat of a person with the in-
fection.  
 
Symptoms include fever, headache, and 
stiff neck for meningitis and rash and 
sepsis for meningococcemia.  The 
symptoms are indistinguishable from 
other pathogens causing  meningitis. 
 
 4 cases represent an increase from 3 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 5 
 Median age was 65 years 
 Age range was 55 to 79 years 
 Cases were 50% female and 50% 
male 
 Serogroups identified include: B (1), 
Y (2), and not groupable (1) 
 
There are at least thirteen known Neis-
seria meningitidis serogroups, and there 
is currently a vaccine available for the 
four serogroups that cause the majority 
of infections (serogroups A, C, Y, and 
W-135). The vaccine is recommended 
for all adolescents, college students, 
military recruits, overseas travelers, and 
any other persons at increased risk of 
infection. To prevent the spread of dis-
ease, chemoprophylaxis is available for 
persons who have close and direct con-
tact with a person with the infection. 
Meningococcal Disease by Age and Gender, 
Maine, 2013
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MRSA, invasive 
2013 Case Total 130 
Maine Rate  9.8 per 100,000 
U.S. rate (2012) Not reportable 
Invasive MRSA Incidence, Maine, 2009-2013
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Methicillin-resistant Staphylococcus 
aureus (MRSA) is caused by a strain of 
bacteria which is resistant to the antibi-
otic methicillin and many of the antibi-
otics commonly used to treat staphylo-
coccal infections. MRSA usually pre-
sents as a skin or soft tissue infection, 
considered a non-invasive infection.  
Invasive MRSA occurs when the bacte-
ria  infect internal systems and are iso-
lated from a normally sterile site (such 
as blood, CSF, pleural fluid or joint flu-
id) 
 
Persons with weakened immune sys-
tems, the elderly, and those with inva-
sive medical devices are at increased 
risk of invasive MRSA infections. 
 
 130 cases represent an increase from 
116 cases in 2012 
 Median age was 66 years 
 Age range was 6 days to 96 years 
 Cases were 39% female and 61% 
male 
 
To reduce MRSA transmission cover 
wounds with clean dry bandages; wash 
hands frequently with soap and warm 
water; use disinfectants effective against 
S. aureus; avoid sharing personal items 
such as towels, washcloths, razors, and 
clothing; tell your healthcare provider if 
you had contact with someone with 
MRSA; and avoid contact sports and 
other skin-to-skin contact until your 
infection heals. Seek medical care im-
mediately to identify infection early and 
receive treatment for invasive MRSA 
infection. 
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Mosquito Borne Infections 
Mosquitoes are blood-feeding insects found 
around the world.  Female mosquitoes need a 
blood meal to reproduce, making them an im-
portant disease vector.  There are 45 species of 
mosquitoes in Maine; however less than half are 
capable of spreading diseases including EEE and 
WNV. 
 
Eastern Equine Encephalitis (EEE) 
EEE is a mosquito-borne viral disease that occurs 
in the eastern half of the United States where it 
can cause disease in humans, horses, and some 
birds.  Most persons infected with EEE will have 
no obvious symptoms.  In those persons who do 
develop illness, symptoms of EEE range from 
mild-flu like illness to inflammation of the brain, 
coma, and death.  EEE is one of the most serious 
mosquito-borne diseases in the United States be-
cause of its high mortality rate. 
 
In 2013, 26 mosquito pools tested positive for 
EEE from York county. Other animals with posi-
tive EEE include three horses (York, Oxford and 
Somerset counties), one emu (Cumberland coun-
ty), and one pheasant (York county). There were 
no human cases of EEE. 
 
West Nile Virus (WNV) 
WNV occurs throughout the United States and 
can cause disease in humans, birds, and other 
mammals.  Many persons infected with WNV 
will have no obvious symptoms.  In those per-
sons who do develop illness, symptoms of WNV 
include:  headache, high fever, altered mental 
state, tremors, convulsions, and rarely paralysis.  
WNV can also cause meningitis and/or encepha-
litis and can be fatal. 
 
In 2013, three mosquito pools from York County 
tested positive for WNV in Maine. 
 
Chikungunya  
In 2013, one case of Chikungunya with travel to 
the Philippines was reported to the state. 
Chikungunya is a disease caused by a virus trans-
mitted by the bite of an infected mosquito.  
Symptoms include fever, joint pain, headache, 
muscle pain, joint swelling and rash. 
Dengue Fever 
In 2013, one case of Dengue fever with travel to 
the Philippines was reported to the state. Dengue is 
a disease caused by a virus transmitted by the bite 
of an infected mosquito.  Symptoms of dengue fe-
ver include high fever, severe headache, backache, 
joint pain, nausea and vomiting, eye pain and rash.  
 
Malaria 
Malaria is a serious and sometime fatal disease 
caused by a parasite that commonly infects a cer-
tain type of mosquito.  Symptoms may include high 
fevers, shaking chills, flu-like illness, headache, 
muscle aches, tiredness, nausea, vomiting and diar-
rhea.  Malaria is uncommon in the United States, 
but very common in developing countries. 
 
In 2012, there were 10 cases of malaria reported in 
Maine individuals who had a history of travel out-
side the US (Angola, Chad, India, Nigeria, Sudan, 
Zambia, Zimbabwe).  
 
Prevention  
To decrease risk of contracting a mosquito-borne 
disease, measures should be taken to prevent mos-
quito bites: 
 Use an EPA approved repellent. Products con-
taining DEET, IR3535, picaridin or oil of lem-
on eucalyptus can be applied to exposed skin, 
and permethrin containing products can be ap-
plied to clothing.  Make sure to follow the in-
structions on the product’s label when using 
repellents or other pesticides 
 Wear long sleeve shirts and long pants when 
possible or when mosquitoes are abundant 
 Protect babies with mosquito netting 
 When mosquitoes are abundant, stay indoors 
 Mosquito proof your house by fixing or in-
stalling window screens and screen doors 
 Control mosquito populations around your 
home by cleaning gutters and removing or 
emptying objects that contain still water where 
mosquitoes can lay eggs such as old tires, old 
cans,  and plastic tarps  
 Empty water from flower pots, pet dishes, bird-
baths, rain barrels, and buckets at least weekly 
 Prior to international travel, consult a travel 
clinic to determine if malaria prophylaxis is 
recommended for the country of visitation 
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Pertussis 
2013 Case Total 332 
Maine Rate 25.0 per 100,000 
U.S. rate (2012) 15.4 per 100,000 
Pertussis Incidence, Maine and US, 2009-2013
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Pertussis (whooping cough) is a bacteri-
al infection of the respiratory tract 
caused by Bordetella pertussis.  Prior to 
vaccine licensure pertussis was a com-
mon childhood disease associated with a 
high mortality rate. High pertussis vac-
cination rates are associated with lower 
numbers of pertussis cases. 
 
Symptoms include an irritating cough 
lasting at least 2 weeks with paroxysm, 
whoop, and post-tussive vomiting. 
 
 332 cases represent a decrease from 
737 cases in 2012 
 The 2008-2012 median number of 
cases per year was 80 
 Median age was 10 years 
 Age range was 24 days to 79 years 
 Cases were 51% female and 49% 
male 
 Oxford, Piscataquis and Waldo coun-
ties had the highest incidence 
 166 (50%) cases are in children who 
attend school 
 
Vaccination is available and part of rou-
tine childhood immunizations.  There 
are two pertussis vaccines (DTaP and 
Tdap). The ACIP recommends all per-
sons 11 years and older receive Tdap in 
place of one tetanus booster. 
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Rabies, Animal 
2013 Case Total 50 
Maine Rate N/A 
U.S. Count (2012) 6,163 
Animal Rabies, Maine, 2004-2013
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Rabies is a zoonotic viral disease that 
affects the central nervous system. All 
mammals are susceptible to rabies. Ra-
bies in humans is rare in the United 
States. The majority of rabies infections 
occur in wild animals, including rac-
coons, skunks, foxes, and bats. Unvac-
cinated domestic animals are also at risk 
for getting and spreading rabies. 
 
The rabies virus is found in the saliva 
and neural tissue of infected animals. 
Rabies is transmitted from the bite of a 
rabid animal. Rabies can also be spread 
if infectious material from a rabid ani-
mal gets into an open wound or mucous 
membrane (eyes, nose, or mouth) of a 
susceptible person or animal. Bat bites 
can be difficult to detect. Since bats are 
implicated in most human rabies cases, 
whether or not a bite was reported, any 
contact with a bat should be evaluated 
by a healthcare provider. 
 
Rabies infection causes acute progres-
sive encephalopathy. Early symptoms 
include fever and general discomfort. 
As the disease progresses, symptoms 
may include difficulty sleeping, anxiety, 
confusion, hallucinations, excessive 
drooling, difficulty swallowing, and 
hydrophobia. Rabies is almost always 
fatal after symptoms appear.  
 
 50 animal rabies cases represent a 
decrease from 91 cases in 2012 
 The 2008-2012 median number of 
cases per year was 66 
 The last reported case of human 
rabies in Maine was in 1937 
 81 persons were recommended to 
receive PEP; 12 were exposed to a 
laboratory-confirmed rabid animal 
 
 
Rabies testing requires central nervous system or brain tis-
sue, obtained postmortem. The state public health laborato-
ry uses direct fluorescent antibody testing to determine if 
wild or domestic animals that expose people or domestic 
animals are rabid.   
 
Maine CDC works with Animal Control Officers, Game 
Wardens, veterinarians, and healthcare providers to recom-
mend control measures for people and domestic animals 
after an exposure. Persons who are exposed to a laboratory-
confirmed rabid animal should receive rabies post-exposure 
prophylaxis (PEP), which is a combination of rabies vac-
cine and immune globulin. Rabies PEP is very effective in 
preventing disease after an exposure. 
 
Increased public awareness about rabies may reduce the 
number of exposures. Prevention measures include keeping 
pets up-to-date on rabies vaccine and avoiding wildlife. 
Positive Rabies Results by Species, Maine, 2013 
Animal Number 
Positive 
Raccoon 20 
Skunk 19 
Fox 4 
Bat 7 
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Salmonellosis 
2013 Case Total 131 
Maine Rate 9.9 per 100,000 
U.S. rate (2012) 17.1 per 100,000 
Salmonellosis Incidence, Maine and US, 
2009-2013
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Salmonellosis is a gastrointestinal ill-
ness of varying severity caused by Sal-
monella bacteria.  Severity of symptoms 
depends on the age and overall health of 
the person infected, serotype of Salmo-
nella and the site of infection. Salmonel-
la is transmitted through the ingestion 
of contaminated meat, poultry, eggs, 
unpasteurized dairy, and fresh produce. 
Handling of reptiles, chicks, domestic 
birds, and pets can also lead to transmis-
sion. 
 
The symptoms can include: fever, 
cramping, diarrhea, nausea, and vomit-
ing.  
 
 131 cases represent a decrease from 
161 cases in 2012 
 The 2008-2012 median number of 
cases per year was 134  
 Median age was 40 years 
 Age range was 2 months to 92 years 
 Cases were 46% female and 54% 
male 
 123 of 131 (94%) cases were labora-
tory confirmed 
 The most commonly seen types of 
Salmonella were Enteritidis,  New-
port and Typhimurium 
 
The best way to reduce the risk of sal-
monellosis is to wash produce, avoid 
consuming unpasteurized dairy prod-
ucts, and follow proper cooking instruc-
tions. Individuals having contact with 
reptiles (such as snakes, lizards, turtles, 
frogs, iguanas, etc.), birds, poultry and 
farm animals should wash their hands 
immediately after handling these ani-
mals. 
*Date of onset missing for 3 cases. 
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Shiga toxin-producing  
E. coli (STEC) 
2013 Case Total 27 
Maine Rate 2.0 per 100,000 
U.S. rate (2012) 2.1 per 100,000 
STEC Incidence, Maine and US, 2009-2013
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Escherichia coli (E. coli) are common 
bacteria that live in the digestive tract, 
some cause serious infection and some 
do not. Transmission of shiga toxin-
producing E. coli (STEC) is through 
consumption of food or water contami-
nated with fecal matter or through con-
tact with farm animals. Commonly im-
plicated food items include under-
cooked meats, raw vegetables, and un-
pasteurized products.  
 
STEC may cause severe illness. Symp-
toms include: abdominal cramping, 
bloody diarrhea and a rare complication, 
hemolytic uremic syndrome (HUS), 
which can damage red blood cells and 
the kidneys. 
 
 27 cases represent an increase  from 
20 cases in 2012 
 The 2008-2012 median number of 
cases per year was 21 
 Median age was 20 years 
 Age range was 1 year to 82 years 
 Cases were 56% female and 44% 
male 
 23 of 27 (85%) cases were laboratory 
confirmed 
 43% of laboratory confirmed cases 
were O157:H7  
 2 cases of hemolytic uremic syn-
drome (HUS) with symptoms of diar-
rhea were reported, one confirmed 
with O121 
 
STEC prevention measures include: 
handwashing, particularly before and 
after cooking and after contact with ani-
mals; thoroughly cooking meats; wash-
ing fresh fruits and vegetables; avoiding 
raw dairy products and unpasteurized 
juices; avoiding consumption of untreat-
ed water; and avoiding cross-
contamination of food items. 
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Shigellosis 
2013 Case Total 5 
Maine Rate 0.4 per 100,000 
U.S. rate (2012) 4.9  per 100,000 
Shigellosis Incidence, Maine and US, 2009-2013
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Shigellosis is a gastrointestinal illness 
caused by Shigella bacteria. Shigella is 
highly infectious and can easily be 
passed from one person to another 
through the fecal-oral route. Shigellosis 
can be transmitted by eating contami-
nated food, and drinking, swimming in 
or playing with contaminated water. 
Outbreaks of Shigella have also oc-
curred among men who have sex with 
men. 
 
Symptoms include: fever, stomach 
cramping and severe diarrhea which 
may be bloody. Shigellosis is easily 
spread among household members. 
 
 5 cases represent a decrease from 7 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 8 
 Median age was 55 years 
 Age range was 11 to 64 years 
 Cases were 20% female and 80% 
male 
 All cases were laboratory confirmed 
 Shigella flexneri and sonnei were 
identified 
 3/5 (60%) cases had travel to a for-
eign country during exposure period 
 
To prevent shigellosis, practice good 
hand hygiene, avoid consuming unpas-
teurized milk products,  use filtered, 
clean water, and store foods properly.  
Infected persons who are employed in 
childcare, healthcare, or food handling 
are restricted from work until infection 
clears and there is no evidence of Shi-
gella in stool specimens. Shigellosis is 
more common in the developing world 
and travelers should take extra precau-
tions. 
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Streptococcus pneumoniae,  
invasive  
2013 Case Total 121 
Maine Rate 9.1 per 100,000 
U.S. rate (2012) 5.0 per 100,000 
Invasive S. pneumoniae Incidence, Maine and 
US, 2010-2013
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Starting in 2010, all cases of invasive 
disease were investigated and reported. 
Prior to 2010 only drug resistant cases 
and illness in children under 5 years 
were reported to federal CDC. 
 
Invasive pneumococcal disease occurs 
when the Streptococcus pneumoniae 
bacterium infects the blood, lungs, or 
brain.  Disease is transmitted from per-
son to person through droplets when an 
infected person coughs or sneezes.  
Types of illness include bacteremia, 
meningitis, and pneumonia.  There are 
over 90 different serotypes of S. pneu-
moniae, but the majority of pneumococ-
cal disease is caused by a few common 
serotypes.   
 
Persons at risk of pneumococcal disease 
include young children, adults 65 years 
of age or older, persons with certain 
underlying medical conditions, persons 
with weakened immune systems, and 
those in congregate settings such as 
daycare and long-term care facilities. 
 
 121 cases represent an increase from 
102 cases in 2012 
 Median age was 68 years 
 Age range was 8 months to 101 years 
 Cases were 52% female and 48% 
male 
 31 (26%) cases were drug resistant  
 6 cases were in children under the age 
of five (2 cases were drug resistant) 
 
Pneumococcal disease can be prevented 
through routine vaccination of infants 
and children under five years with the 
pneumococcal conjugate vaccine 
(PCV13) and vaccination of adults and 
children over the age of two who are at 
high risk of infection with the pneumo-
coccal  polysacchar ide  vacc ine 
(PPSV23).  
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 Early Syphilis 
2013 Case Total 16 
Maine Rate 1.2 per 100,000 
U.S. rate (2012) 9.7 per 100,000 
Early Syphilis Incidence, Maine and US, 
2009-2013
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Syphilis is a sexually transmitted dis-
ease (STD) caused by the bacterium 
Treponema pallidum.  It has often been 
called “the great imitator” because so 
many of the signs and symptoms of 
syphilis are like those of other diseases.  
 
Early syphilis is defined as disease that 
occurs within the first year of infection.  
This is inclusive of the primary, second-
ary, and early latent stages of the dis-
ease.   
 
Syphilis is primarily spread through 
direct contact with a primary syphilis 
lesion.  Lesions typically occur on the 
external genitals, vagina, and around the 
anus, but are also seen on the lips and in 
the mouth.  Transmission primarily oc-
curs during vaginal, anal, or oral sex. 
Disease transmission can also occur 
during the infectious period of the sec-
ondary stage, via the condylomata lata 
(raised moist papules) on the genital 
area or mucous patches in the mouth.  
Pregnant women with syphilis can pass 
it to their baby.  Genital lesions caused 
by syphilis make it easier to transmit 
and acquire HIV infection.   
 
16 cases represents a decrease from 
19 cases in 2012  
 The 2009-2013 median number of 
cases per year was 19 
 Median age was 34 years 
 Age range was 22 to 55 years 
 15 (94%) of the cases were male, 
with only one female case (6%)  re-
ported 
 11 (69%) of 16 cases were self-
identified men who have sex with 
men 
 
Many individuals infected with syphilis reach a latent stage 
and have no symptoms for years, but they are still at risk for 
later complications (damage to internal organs, nerve dam-
age, blindness and dementia) and death if not treated.  
 
Syphilis transmission can be prevented by the use of latex or 
polyurethane condoms and dental dams during anal, vaginal, 
and oral sex. Prevention and control efforts include targeted 
awareness messaging  (including the internet) and disease 
intervention activities for all early syphilis cases. Disease in-
tervention activities include ensuring adequate treatment and 
notifying partners of potential exposure.  
Early Syphilis by Age and Gender, Maine, 2013 
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Tuberculosis 
2013 Case Total 15 
Maine Rate 1.1 per 100,000 
U.S. rate (2012) 3.2 per 100,000 
Tuberculosis Incidence, Maine and US, 
2009-2013
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Tuberculosis (TB) is a communicable 
disease caused by the bacterium, Myco-
bacterium tuberculosis.  It is spread 
through the air by airborne particles 
called droplet nuclei that are expelled 
from the lungs when a person who has 
infectious TB coughs, sings or sneezes.  
TB occurs when the mycobacterium is 
inhaled into the lung and begins to mul-
tiply.  Not everyone infected with TB 
bacteria becomes sick. As a result, two 
TB-related conditions exist: latent TB 
infection (LTBI) and active TB disease. 
 
TB disease can cause infection in the 
lung (pulmonary), which is considered 
infectious to others. TB disease can also 
o c c u r  o u t s i d e  o f  t h e  l u n g 
(extrapulmonary), which is not infec-
tious. 
 
 15 cases represent a decrease from 17 
cases in 2012 
 The 2008-2012 median number of 
cases per year was 9 
 Median age was 55 years 
 Age range was 1 to 89 years 
 Cases were 47% female and 53% 
male 
 7 (47%) were foreign born 
 In 7 contact investigations, 96% of 
identified contacts were evaluated 
 Of 433 LTBI reports, 82% were for-
eign born 
 
All active TB cases are evaluated by a 
healthcare provider in consultation with 
a TB consultant physician; and are mon-
itored by the state TB Control Program 
and Public Health Nurses.  
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Varicella 
2013 Case Total 140 
Maine Rate 10.5 per 100,000 
U.S. rate (2012) 4.3 per 100,000 
Varicella Incidence, Maine and US, 2009-2013
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Varicella (chickenpox) is a highly con-
tagious viral disease of which humans 
are the only source of infection.   Most 
illness includes an itchy skin rash that 
looks like blisters, covering the body 
but  more evident on the face, scalp, and 
abdomen. The majority of infected indi-
viduals develop a fever just before or 
when the rash appears.  
 
Person-to-person transmission occurs 
primarily through direct contact with 
respiratory tract secretions of infected 
individuals.  Adolescents and adults are  
at higher risk for severe disease which 
could include pneumonia, bacterial in-
fection of the skin and swelling of the 
brain.  
 
 140 cases represent a decrease from 
258 cases in 2012 
 Overall the greatest incidence was 
during the fall and spring months 
while schools are in session 
 Nationally varicella incidence is re-
ported to be an underestimate of true 
incidence 
 
Varicella vaccine is a live attenuated 
viral vaccine.  A two-dose series is esti-
mated to be more than 90% effective in 
preventing infection. Federal CDC and 
ACIP recommend that all children re-
ceive 2 doses of varicella vaccine. 
Breakthrough infection has been report-
ed in vaccinated individuals.  
 
Mandatory vaccination for varicella 
(one dose) began in 2003 and is a re-
quirement for school admission.   
Varicella by Age and Gender, Maine, 2013
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Vibriosis 
2013 Case Total 9 
Maine Rate 0.7 per 100,000 
U.S. rate (2012) 0.4 per 100,000 
Vibriosis Incidence, Maine and US, 2009-2013
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Vibriosis is an infection of variable se-
verity characterized by diarrhea and 
vomiting, primary septicemia, or wound 
infections. Vibrio parahaemolyticus, 
associated with ingestion of raw or un-
dercooked seafood, and Vibrio algino-
lyticus, associated with wounds and wa-
ter contact, are the primary causes of 
vibriosis in Maine. 
 
 9 cases represent a decrease from 10 
cases in 2012  
 The 2008-2012 median number of 
cases was 4  
 Median age was 38 years 
 Age range was 17 to 80 years 
 Cases were 44% female and 56% 
male 
 Vibrio parahaemolyticus, alginolyti-
cus, and Grimontia hollisae were iso-
lated. 
 
Vibrio infections caused by V. parahae-
molyticus can be prevented by thor-
oughly cooking seafood, especially oys-
ters.  Wound infections can be prevent-
ed by avoiding exposure of open 
wounds to seawater.   Maine CDC 
works closely with the Maine Depart-
ment of Marine Resources when per-
sons with vibriosis report having expo-
sures to shellfish or other marine 
sources of illness.  
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Influenza Season 2013—2014 
Influenza 
Influenza is a viral illness that typically occurs 
during the winter months. It is characterized by 
the abrupt onset of constitutional and respirato-
ry signs and symptoms such as fever, head-
ache, non-productive cough, sore throat, and 
runny nose.  Influenza is spread from person to 
person primarily through coughing and sneez-
ing of infected persons.  Influenza can be diag-
nosed through laboratory testing.  Influenza-
like illness (ILI) is defined as fever greater than 
or equal to 100°F (37.8°C) AND cough and/or 
sore throat in the absence of a known cause.  
 
The purpose of influenza surveillance is to 
inform influenza prevention and control policy.  
Maine CDC conducted influenza surveillance 
in collaboration with thirty three health care 
providers, four hospitals, three laboratories, 
Maine’s Electronic Death Registry System 
(EDRS), twenty five hospital emergency 
departments, and Maine Emergency Medical 
Services (EMS) during the reporting period 
from September 29, 2013 to May 17, 2014.  
This report summarizes 2013-14 influenza 
surveillance by key indicators.   
 
 
Influenza Surveillance in Maine 
 
Outbreaks 
Outbreaks of influenza or influenza-like illness are 
reportable by law in Maine.  The definition used to 
recognize outbreaks of influenza-like illness varies 
by setting. For example, a single lab confirmed 
case (by any testing method) is an outbreak in long 
term care facilities. During the 2013-14 season, a 
total of 45 outbreaks of influenza were reported in 
Maine. This is a decrease from the 2012 -13 season 
when 167 outbreaks were reported. Of the 45 out-
breaks, 32 were in long term care facilities, 4 in 
acute care facilities, 4 in K-12 schools, and 2 in 
institutions.  The number of outbreaks peaked in 
January (MMWR week 5) and outbreaks occurred 
in 13 counties (all but Franklin, Knox, and York). 
 
Death Certificates 
Maine’s EDRS was used to determine the number 
of death certificates in which pneumonia and/or 
influenza were mentioned as a cause of death.     
Data represents deaths statewide.   During the 2013
-14 season, a total of 8,294 death certificates were 
filed.  Of these 560 (6.8%) were attributed to pneu-
monia or influenza. 
 
Pediatric Fatalities 
Health care providers and the Office of the Medical 
Examiner report deaths in persons aged 18 years or 
younger associated with laboratory-confirmed in-
fluenza to Maine CDC.  One influenza-associated 
pediatric death was reported during the 2013-14 
influenza season.  A child from western Maine died 
with confirmed influenza A/H1N1.   
Appendix A 
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Influenza Season 2013-2014: Inpatient and Outpatient Surveillance 
Outpatient influenza-like illness (ILI) 
Data on outpatient visits for ILI  was 
collected through the U.S. Outpatient 
Influenza-like Illness Surveillance Net-
work (ILINet), a collaborative effort 
between federal CDC, Maine CDC, and 
local health care providers.  During the 
2013-14 season, 33 health care provid-
ers reported the total number of patients 
seen in their practices and the number of 
those patients seen for ILI by age group 
on a weekly basis.  Outpatient ILI visits 
in Maine peaked in January (MMWR 
week 5) The New England region  
peaked in January, with a second peak 
in April.  
 
Hospital Inpatients 
Inpatient surveillance for respiratory 
illness admissions in Maine was con-
ducted in collaboration with four hospi-
tals.  During the 2013-14 season, four 
hospitals reported the number of pa-
tients admitted to the hospital and the 
number of those patients admitted for 
influenza  or pneumonia using admitting 
diagnoses.  Hospital admissions for in-
fluenza, pneumonia, or respiratory ill-
ness were highest in the first week of  
February (MMWR week 6). 
 
Emergency Room Visits 
Syndromic surveillance was conducted 
in the Emergency Departments (ED) of 
25 hospitals, and on all Maine Emergen-
cy Medical Response runs.  The data 
was analyzed using the Early Aberration 
Reporting System (EARS).  These visits 
are grouped by chief complaint.  The 
percentage of ED visits that had a chief 
complaint consistent with ILI peaked in 
February (MMWR week 7).  The per-
centage of EMS runs that had a chief 
complaint consistent with ILI peaked in 
late January (MMWR week 5) 
Hospital Admissions Due to Pneumonia or Influenza, Maine, 2012-14 
Syndromic Surveillance data  for ILI, Maine, 2012-14 
Outpatient Visits for Influenza-like Illness, Maine, 2012-14 
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Influenza Season 2013—2014: Laboratory Surveillance 
HETL 
Maine CDC’s Health and Environmen-
tal Testing Laboratory (HETL) worked 
collaboratively with hospitals and pri-
vate laboratories to collect specimens 
for respiratory virus testing and influen-
za positive isolate subtyping.  HETL 
reported the number of specimens re-
ceived for respiratory virus testing and 
the number positive for influenza A
(pH1N1), A (H3), A (unable to sub-
type), and influenza B by specimen col-
lection date.  During the 2013-14 sea-
son, 1,082 respiratory specimens were 
tested by HETL for influenza.  Of those 
378 (34.9%) were positive for influenza 
(303 for influenza A/pH1N1, 14 for in-
fluenza A/H3,  1 for influenza A unable 
to subtype, and 60 for influenza B). 
 
Reference Labs 
Two Maine reference laboratories, and 
many national reference laboratories 
submitted reports of laboratory-
confirmed influenza by culture or re-
verse-transcriptase polymerase chain 
reaction (RT-PCR).  During the 2013-
14 season,  958 specimens were positive 
for influenza (220 for influenza A/
pH1N1, 12 for influenza A/H3, 548 for 
influenza A without subtype, and 178 
for influenza B). 
 
Rapid testing 
Many hospitals, labs, and physician of-
fices voluntarily report positive rapid 
antigen tests to the state.  During the 
2013-14 season 756 positive tests were 
reported, 606 for influenza A, 130 for 
influenza B, and 20 for influenza, un-
subtyped.   
Positive PCR Samples for Influenza, HETL—Maine, 2013-14 
Positive PCR Samples for Influenza, Maine and National Reference Labs 
Maine, 2013-14 
Rapid Positive Influenza Tests—Maine, 2013-14 
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Latent Tuberculosis Infection – Maine, 2013: Countries and Languages 
Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis. Latent tuberculosis infection 
(LTBI) occurs when M. tuberculosis is present in the body without signs and symptoms, or evidence of 
TB disease. 
 
While active TB is monitored through mandatory reporting, LTBI is not a notifiable condition in Maine. 
The Maine CDC TB Control Program encourages providers to refer all LTBI cases so treatment can be 
covered and high risk individuals can receive Public Health Nursing services.  
 
A total of 433 cases of LTBI were reported in 2013, compared to 398 cases in 2012. Results from Table 
1 and 2 indicate Maine’s TB Program serves a significantly more diverse population of individuals with 
LTBI than makes up the general population of Maine; 15 different languages and 48 countries are repre-
sented. Since incomplete treatment for LTBI is a risk-factor for progression to active disease, this type 
of insight will allow a more culturally and linguistically informed public health response to TB preven-
tion from educational materials to patient services. 
Appendix B 
Table 1. Provider reported languages – Maine, 2013‡ 
Language # % Language # % Language # % 
Acholi 1 0.2 French 109 24.2 Portuguese 13 2.9 
Arabic 48 10.7 Kinyarwanda 7 1.6 Somali 58 12.9 
Burmese 1 0.2 Kirundi 8 1.8 Spanish 8 1.8 
Cambodian 1 0.2 Korean 1 0.2 Swahili 1 0.2 
English 190 42.2 Lingala 2 0.4 Tigrinya 2 0.4 
‡ Languages not mutually exclusive 
Table 2. Provider reported country of birth – Maine, 2013* 
Country # % Country # % Country # % 
Afghanistan 1 0.2 Ethiopia 4 0.9 Romania 1 0.2 
Albania 1 0.2 Ghana 2 0.5 Rwanda 38 8.8 
Angola 41 9.5 Haiti 5 1.2 Saint Kitts and Nevis 1 0.2 
Benin 1 0.2 Iraq 41 9.5 Saint Lucia 1 0.2 
Burundi 43 10.0 Jamaica 6 1.4 Saudi Arabia 1 0.2 
Cambodia 2 0.5 Jordan 1 0.2 Senegal 1 0.2 
Cameroon 2 0.5 Kenya 4 0.9 Solomon Islands 2 0.5 
Canada 3 0.7 Korea, DPRK 1 0.2 Somalia 53 12.3 
China 1 0.2 Kuwait 3 0.7 South Africa 1 0.2 
Colombia 1 0.2 Maldives 1 0.2 Sudan 4 0.9 
Congo 51 11.8 Mexico 2 0.5 Turkey 2 0.5 
Dem Rep of Congo 1 0.2 Myanmar 1 0.2 Uganda 3 0.7 
Djibouti 6 1.4 Nepal 1 0.2 Tanzania 1 0.2 
Dominican Republic 3 0.7 Netherlands 1 0.2 United States 78 18.1 
El Salvador 1 0.2 Philippines 8 1.9 Uzbekistan 1 0.2 
Eritrea 2 0.5 Puerto Rico 1 0.2 Yemen 1 0.2 
*Unknown country of birth for 2 cases 
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Tuberculosis Cluster in Aroostook County  
In July 2013, a female resident (Patient X) residing in an Aroostook County long-term care facility de-
veloped active tuberculosis (TB).  Patient X had visits to multiple healthcare facilities during her infec-
tious period as well as close contact with peers, friends and family members in the community.  In re-
sponse to the active case, Maine CDC’s TB Control Program staff made a 3-day site visit to affected 
facilities to provide education on TB and latent TB infection (LTBI), discuss a response plan and identi-
fy steps required for a contact investigation.   
 
A contact investigation is when people who had contact with an infected person, like Patient X, get 
screened to find out if they have LTBI or active TB disease.  This is important because with no treat-
ment, 5 – 10% of LTBI infected persons will develop TB disease at some point in their lives.  Determin-
ing who has LTBI  and providing treatment for those individuals reduces their chance of active TB in-
fection.  Persons with LTBI do not spread TB to other people. 
 
Maine CDC’s TB Control Program coordinated a contact investigation involving staff from three medi-
cal centers, one out-patient clinic, one long-term care facility and Public Health Nursing to assess and 
test individuals exposed to Patient X.  Table 1 shows the facilities and number of contacts who were 
screened, initiated therapy, are currently on therapy, or completed treatment.   
 
During the contact investigation, two additional cases of active TB infection were identified.  Both pa-
tients initiated treatment and one died shortly after of a non-TB related illness.  Not all individuals iden-
tified with LTBI initiated or completed therapy.   In some cases, patients did not start treatment per their 
providers’ recommendation, were lost to follow up, or were non-compliant with treatment.  Some pa-
tients are still undergoing treatment.   
 
This cluster demonstrates the value of conducting contact investigations and identifying individuals at 
risk for developing LTBI and active TB disease, the need for medical staff to use proper precautions in 
caring for patients with respiratory illness, and the need for treatment adherence.   
 
Table 1:  Contact Investigation For Patient X by Facility and Number of Contacts Screened Who 
Initiated or Have Ongoing or Completed Treatment, Aroostook County, 2013.     
Appendix C 
Facility # Contacts # Screened 
(TST) 
# Positive # Initiated 
Treatment 
# Ongo-
ing 
Treat-
ment 
# Completed 
Treatment* 
Medical Center A 36 36 1 1 0 1 
Out-patient clinic 7 7 0 0 0 0 
Public Health 
Nursing 
104 104 11 5 2 2 
Medical Center B 21 21 0 0 0 0 
Medical Center C 117 117 4 4 1 1 
LTC Facility 250 236 18 11 3 1 
Total 535 521 34 21 6 5 
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Raccoons, Skunks, Foxes, and Bats – Oh My! 
Though the occasional woodchuck, bobcat, or domestic cat test positive for rabies, all the rabid animals 
in 2012 were raccoons, skunks, foxes, and bats. These four species remain the primary infected species 
in Maine. Epidemiologists respond to calls about suspect rabid animals with potential exposure to a hu-
man or domestic animal. Following investigation, epidemiologists make recommendations based on na-
tional guidance for testing or confinement and observation of attacking wild and domestic animals, re-
spectively. They also recommend control measures for exposed persons and domestic animals to prevent 
the spread of rabies. The following are highlights from two selected animal rabies investigations in 
2013. 
 
The tenacious fox 
In July, a rabid fox bit five victims in a densely-populated region in Cumberland County before being 
captured. Victims included: 
 44 year old male, Maine resident: Was bitten by the fox while sitting in his truck in a parking lot. He 
attempted to run over the fox, but it escaped. 
 51 year old male, Florida resident: Was out for a morning jog when the fox approached him and 
knocked him to the ground. It continued to scratch him as he lay on the ground, and then escaped. 
 21 year old female and 23 year old male, Ohio residents: Were camping when the fox gave them a 
wakeup call. It bit the male in the face and bit the female on the leg and ankle before escaping.  
 37 year old male, Maine resident: Was entering his office building when the fox chased him and 
scratched his legs. The fox entered the office building and was trapped in the vestibule. 
 
Animal Control and Law Enforcement dispatched the fox and submitted it to the Health and Environ-
mental Testing Laboratory (HETL), where it tested positive for rabies. Epidemiologists determined ex-
posures and recommended post-exposure prophylaxis (PEP) for all exposed persons. The investigation 
required collaboration with law enforcement and interstate notifications to Ohio and Florida health de-
partments about their residents’ exposure. The story was covered by two local TV stations, local radio 
stations, and print media. Maine CDC collaborated with local media to promote the disease reporting 
line for notification if persons were concerned about exposure. 
 
Bat in the schoolyard  
In November, a bat from Penobscot County tested positive for rabies at HETL.  According to the sub-
mission form, it had bitten a 17 year old high school student. The bat was found in an elementary school 
playground that is next door to a high school. Aspects of the investigation included contacting: 
 Both schools to inform them of the situation and, because of unknown potential exposures, recom-
mend a letter to parents 
 The exposed student’s parents to recommend rabies PEP 
 The hospital emergency department to verify that rabies vaccine and immune globulin were availa-
ble 
The  student and friends were walking through the elementary schoolyard in the afternoon and saw a 
group of children looking at a bat.  While attempting to get the bat away from the children, the student 
was bitten on the finger. The bat was safely collected and transported to HETL by a Game Warden. A 
memo was sent to the Superintendent for distribution to schools, and information was provided to local 
hospitals should other potentially-exposed students come forward. 
 
Appendix D 
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Salmonella Typhimurium Associated with a Maine College Microbiology Laboratory  
Salmonellosis is a bacterial gastrointestinal infection that can cause fever, abdominal pain, diarrhea, and 
vomiting.  An estimated 1.2 million cases of salmonellosis occur annually in the U.S. with 23,000 hospi-
talizations and 450 deaths.  Salmonella is transmitted through contaminated food or water, or contact 
with infected persons or animals. During 2010-2011, a national outbreak of Salmonella Typhimurium 
associated with exposure to specimens used in clinical and teaching laboratories sickened 109 people in 
38 states (http://www.cdc.gov/salmonella/typhimurium-laboratory/011712/index.html). 
 
In May, 2013 two cases of Salmonella Typhimurium from Cumberland County with common exposure 
to a Maine college were reported to Maine CDC.  A Maine CDC investigation determined that the cases 
were associated with the same microbiology class and laboratory. The class used Salmonella Typhimuri-
um in an assignment, designed for students to culture and identify “mystery bacteria.” Isolates from the 
case specimens and the Salmonella Typhimurium culture from the college laboratory were tested at the 
Maine Health and Environmental Testing Laboratory (HETL) and were indistinguishable by pulsed-field 
gel electrophoresis (PFGE) to each other and to the 2010-2011 national outbreak.  
 
A total of 106 students in 8 laboratory sections were enrolled in the college microbiology courses that 
utilized the Salmonella culture in two laboratories. Several other courses were held in the laboratories 
where the Salmonella culture was stored.  Interviews with college laboratory staff, a site visit by Maine 
CDC epidemiologists and HETL staff, and an e-mail survey on laboratory practices distributed to micro-
biology students (Table 1) identified several areas of potential contamination: equipment in disrepair, 
inconsistent use of personal protective equipment, break-downs in hand hygiene, inappropriate storage 
and handling of laboratory coats, challenges with cleaning/disinfecting surfaces, and use of personal 
items (pens/pencils, notebooks, phones) not dedicated to the laboratory. Maine CDC communicated 
findings from the survey and recommendations to the University to prevent future illness. A letter with 
additional recommendations was sent to all colleges and Universities with microbiology classes alerting 
them to the risks of using Salmonella in entry-level microbiology courses.  
 
Table 1. Selected responses to the survey on laboratory practices. 
Appendix E 
Laboratory Practice Percent 
Received education/orientation 100% 
Use gloves when working with bacteria  26.7% 
Always wash hands after removing gloves  71.4% 
Always wear a laboratory coat in the laboratory  73.3% 
Store laboratory coats in cubby or hook in laboratory  30.8% 
Take laboratory coats home  46.2% 
Wash laboratory coat at home  46.2% 
Use the same pen/pencil in, and outside of, laboratory  80.0% 
Use cell phone at the laboratory bench  26.7% 
Store backpacks, books, other materials at laboratory bench  21.4% 
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Electronic Laboratory Reporting to Maine CDC 
Historically, test results for notifiable conditions in the State of Maine have been transmitted to the 
Maine Center for Disease Control and Prevention (Maine CDC) by hospitals and reference laboratories 
through  paper-based methods such as fax and mail or via telephone.  Maine CDC uses the federal CDC-
developed National Electronic Disease Surveillance System (NEDSS) based system (NBS) for disease 
surveillance, which is designed to receive electronic laboratory reports (ELR).  Maine CDC utilizes the 
infrastructure of HealthInfoNet, the State of Maine’s health information exchange (HIE), to facilitate 
and standardize electronic messaging from Maine-based hospitals and reference laboratories. This work 
is accomplished through collaboration between  epidemiologists, Department of Health and Human 
Services  Office of Information Technology (DHHS OIT), HealthInfoNet, hospital lab technicians 
and hospital IT services or vendors. 
The benefits of connecting to hospitals to receive ELR are improved timeliness, reduced manual 
data entry errors, and more complete reporting.  ELR has been promoted as a public health priority 
for the past several years and its inclusion as a meaningful use objective for public health serves as 
a catalyst to accelerate its adoption. As part of the meaningful use initiative, ELRs will be standard-
ized based on national guidelines.  
HealthInfoNet is collaborating with hospitals (one currently sending data) and the two regional ref-
erence laboratories in the state to send ELR. Maine CDC receives ELRs directly from four national 
reference laboratories. Additional hospital and national laboratories are testing messages and will 
soon be sending ELR. 
 
 
 
 
 
 
 
 
 
 
 
Appendix F 
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2013 Tick Data Collected by the Maine Medical Center Research Institute 
Vector-Borne Disease Laboratory 
 
The Maine Medical Center Research Institute (MMCRI) Vector-Borne Disease Laboratory operated a 
free tick identification service as part of a program to establish the distribution of deer ticks (Ixodes 
scapularis) in the state. Ticks found on people and pets were submitted with information on where the 
tick(s) may have been acquired. Ticks were not tested for the presence of Lyme bacteria and MMCRI 
only accepted ticks from the state of Maine. 
 
It is important to note that this passive sampling could be influenced by a variety of extraneous factors 
(e.g. proximity to the laboratory, level of citizen concern about Lyme disease in an area, or whether or not 
a particular area is already widely known to have a deer tick presence). 
 
Number of Ticks Identified by County and Type, Maine, 2013 
 County 
Ixodes 
scapularis 
(Deer tick) 
Dermacentor 
variabilis 
(American 
dog tick) 
Ixodes 
cookei 
(Woodchuck 
tick) 
A. 
americanum 
(Lonestar 
tick) 
Androscoggin 15 1 0 0 
Aroostook 4 0 0 0 
Cumberland 81 35 1 1 
Franklin 11 5 1 0 
Hancock 126 9 5 0 
Kennebec 30 8 0 0 
Knox 18 5 0 0 
Lincoln 8 2 0 0 
Oxford 5 5 0 0 
Penobscot 54 6 4 0 
Piscataquis 9 0 2 0 
Sagadahoc 9 0 0 0 
Somerset 12 7 2 0 
Waldo 41 3 1 0 
Washington 4 0 0 0 
York 43 11 0 0 
Unspecified 27 2 0 0 
Totals 497 99 16 1 
 
Why is it important to submit ticks for identification? 
It is important for a physician (or a pet's veterinarian) to know what species of tick was involved in a 
bite.  It is also important for surveillance purposes to know the type of tick and where ticks are found. 
 
What diseases are carried by which ticks? 
Ixodes scapularis (Deer tick) – Lyme disease, Anaplasmosis and Babesiosis 
Dermacentor variabilis (American dog tick) – Rocky Mountain Spotted Fever 
Ixodes cookei (Woodchuck tick) - Powassan  
Amblyoma americanum (Lonestar tick) - Ehrlichiosis 
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How are ticks removed? 
Remove ticks by grasping them with fine tweezers as near to the skin as possible and pull up gently but 
firmly.  A tick spoon is also effective. The barbed mouth parts may not let go easily.  It may take several 
minutes or more.  Do not handle ticks with bare hands.  
How are ticks submitted? 
Please note the change in laboratories for 2014 submissions. 
 
Tick identification is now being performed at the University of Maine Cooperative Extension Tick ID 
Lab and costs $10 per tick. Instructions for submitting a tick are available at: 
http://extension.umaine.edu/ipm/tickid/submit/. 
Place ticks in a small leak-proof container (no glass) with just enough rubbing alcohol to cover the 
specimen. Wrap the container in a paper towel and place inside a zipper-locking plastic bag. Include a 
submission form and a check or money order for $10/per tick or use the online tick submission form. Mail 
ticks to: 
UMaine Extension Tick ID Lab 
491 College Avenue 
Orono ME 04473-1295 
 
Ticks can also be dropped off at the office from 8:00 am – 4:30 pm Monday – Friday. 
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  NOTIFIABLE CONDITIONS LIST   
  Maine Department of Health and Human Services 
    Center for Disease Control and Prevention 
 Conditions in BOLD must be reported immediately   All others must be reported in 48 hours 
Reportable Disease or Condition Laboratory Specimen Submission 
Acquired Immunodeficiency Syndrome (AIDS) 
Anthrax   
Arboviral Infection  
Babesiosis 
Botulism  
Brucellosis  
Campylobacteriosis 
Carbon Monoxide Poisoning, including 
- Clinical signs, symptoms or known 
exposure consistent with diagnosis of 
 carbon monoxide poisoning and/or: 
 a carboxyhemoglobin (COHb) level  
 >5% 
Chancroid 
Chlamydia 
Chickenpox (Varicella) 
Creutzfeldt-Jakob disease, <55 years of age 
Cryptosporidiosis 
Dengue 
Diphtheria  
E. coli, Shiga toxin-producing (STEC) disease 
   including E. coli: 0157:H7     
Ehrlichiosis 
Giardiasis 
Gonorrhea 
Haemophilus influenzae disease, invasive, 
   include all serotypes     
Hantavirus, pulmonary syndrome 
Hemolytic-uremic syndrome (post-diarrheal) 
Hepatitis A, B, C, D, E (acute) 
Hepatitis B (chronic, and/or perinatal) 
Hepatitis C (chronic) 
Hepatitis, acute (etiologic tests pending or 
  etiology unknown) 
Human Immunodeficiency Virus (HIV), 
   including: 
- Confirmed, positive antibody tests 
- Viral load tests, all results  
- CD4 lymphocyte counts, all results 
Influenza-associated pediatric death 
Influenza-like illness outbreaks 
Influenza A, Novel 
Legionellosis 
Leptospirosis 
Listeriosis  
Lyme Disease  
Malaria 
Measles   
Meningitis (bacterial) 
Meningococcal Invasive Disease  
Mumps  
Paralytic Shellfish Poisoning 
Pertussis  
Plague 
Poliomyelitis 
Psittacosis 
Q Fever  
Rabies (human and animal)  
Rabies Post-Exposure Prophylaxis 
Ricin Poisoning  
Rocky Mountain Spotted Fever 
Rubella (including congenital)  
Salmonellosis  
Severe Acute Respiratory Syndrome 
  (SARS) 
Shigellosis  
Smallpox  
Staphylococcus aureus, Methicillin- 
  Resistant (MRSA) invasive,  
Staphylococcus aureus with 
  resistance (VRSA) or intermediate 
  resistance (VISA) to Vancomycin   
  isolated from any site 
Staphylococcal enterotoxin B  
Streptococcal invasive disease, Group A 
Streptococcal invasive disease, Group B 
Streptococcus pneumoniae, invasive     
  disease     
Syphilis 
Tetanus  
Toxoplasmosis 
Trichinosis  
Tuberculosis (active and presumptive 
  cases)    
Tularemia  
Unusual or increased case incidence, 
  critical illness, unexplained death(s) 
  of any suspect infectious disease 
Vibrio species, including Cholera  
Viral Hemorrhagic Fever 
Venezuelan equine encephalitis 
Yellow Fever 
Yersiniosis 
Directors of laboratories are to submit cultures or clinical 
specimens for the following to the Maine Health and 
Environmental Testing Laboratory for confirmation, typing 
and/or antibiotic sensitivity:   
Acid-Fast Bacillus 
Bacillus anthracis 
Bordetella pertussis 
Brucella species 
Clostridium tetani 
Clostridium botulinum 
Corynebacterium diphtheriae 
Coxiella burnetii 
Escherichia coli, Shiga toxin-producing 
Haemophilus influenzae 
Human Immunodeficiency Virus 
Influenza virus, Novel 
Listeria monocytogenes 
Mumps virus 
Mycobacterium tuberculosis 
Neisseria meningitidis 
Rabies virus 
Ricin Poisoning 
Rubella virus 
Rubeola virus 
Salmonella species 
SARS Coronavirus 
Shigella species 
Toxoplasma gondii 
Variola virus 
Vibrio species 
Yersinia pestis 
Who must report: Health Care Providers, Medical Laboratories, Health Care Facilities, 
Administrators, Health Officers, Veterinarians 
When to report: 
 Conditions in BOLD are reportable immediately by telephone on recognition or strong
suspicion of disease
 All others are reportable by telephone, fax, or mail within 48 hours of recognition or
strong suspicion of disease
What to report: 
Disease reports must include as much of the following as is known: 
 Disease or condition diagnosed or suspected
 Patient’s name, date of birth, address, phone number, occupation and race
 Diagnostic laboratory findings and dates of test relevant to the notifiable condition
 Health care provider name, address and phone number
 Name and phone number of person making the report
Complete Rules for the Control of Notifiable Conditions at: 
http://www.maine.gov/dhhs/boh/ddc/epi/disease-reporting/index.shtml  
April 20, 2012 
Disease Reporting 
24 Hours A Day 
7 Days A Week  
Telephone 
1-800-821-5821 
Fax 
1-800-293-7534 
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The Department of Health and Human Services (DHHS) does not discriminate on the 
basis of disability, race, color, creed, gender, age, sexual orientation, or national origin, in 
admission to, access to or operation of its programs, services, activities, or its hiring or 
employment practices.  This notice is provided as required by Title II of the Americans 
with Disabilities Act of 1990 and in accordance with the Civil Rights Acts of 1964 as 
amended.  Section 504 of the Rehabilitation Act of 1973 as amended, the Age 
Discrimination Act of 1975, Title IX of the Education Amendments of 1972 and the 
Maine Human Rights Act.  Questions, concerns, complaints, or requests for additional 
information regarding civil rights may be forwarded to the DHHS’ ADA 
Compliance/EEO Coordinator, State House Station #11, Augusta, Maine 04333, 207-
287-4289 (V) or 207-287-3488 (V), TTY: 800-606-0215.  Individuals who need auxiliary 
aids for effective communication in programs and services of DHHS are invited to make 
their needs and preferences known to the ADA Compliance/EEO Coordinator.  This 
notice is available in alternate formats, upon request. 
 
 
 
 
